<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Cell Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Cell. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Cellular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5102</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30899215</article-id>
<article-id pub-id-type="pmc">6416223</article-id>
<article-id pub-id-type="doi">10.3389/fncel.2019.00077</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Alterations in GABA<sub>A</sub>-Receptor Trafficking and Synaptic Dysfunction in Brain Disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mele</surname>
<given-names>Miranda</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/650786/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Costa</surname>
<given-names>Rui O.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/349566/overview" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Duarte</surname>
<given-names>Carlos B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/275605/overview" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>CNC—Center for Neuroscience and Cell Biology, University of Coimbra</institution>, <addr-line>Coimbra</addr-line>, <country>Portugal</country></aff>
<aff id="aff2"><sup>2</sup><institution>Institute for Interdisciplinary Research, University of Coimbra</institution>, <addr-line>Coimbra</addr-line>, <country>Portugal</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Life Sciences, University of Coimbra</institution>, <addr-line>Coimbra</addr-line>, <country>Portugal</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: David Perrais, Centre National de la Recherche Scientifique (CNRS), France</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Luca Murru, Italian National Research Council (CNR), Italy; Thierry Ralph Nieus, Luigi Sacco Hospital, Italy</p>
</fn>
<corresp id="c001">*Correspondence: Carlos B. Duarte <email>cbduarte@ci.uc.pt</email></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>07</day>
<month>3</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<volume>13</volume>
<elocation-id>77</elocation-id>
<history>
<date date-type="received">
<day>29</day>
<month>11</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>15</day>
<month>2</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Mele, Costa and Duarte.</copyright-statement>
<copyright-year>2019</copyright-year>
<copyright-holder>Mele, Costa and Duarte</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>GABA<sub>A</sub> receptors (GABA<sub>A</sub>R) are the major players in fast inhibitory neurotransmission in the central nervous system (CNS). Regulation of GABA<sub>A</sub>R trafficking and the control of their surface expression play important roles in the modulation of the strength of synaptic inhibition. Different pieces of evidence show that alterations in the surface distribution of GABA<sub>A</sub>R and dysregulation of their turnover impair the activity of inhibitory synapses. A diminished efficacy of inhibitory neurotransmission affects the excitatory/inhibitory balance and is a common feature of various disorders of the CNS characterized by an increased excitability of neuronal networks. The synaptic pool of GABA<sub>A</sub>R is mainly controlled through regulation of internalization, recycling and lateral diffusion of the receptors. Under physiological condition these mechanisms are finely coordinated to define the strength of GABAergic synapses. In this review article, we focus on the alteration in GABA<sub>A</sub>R trafficking with an impact on the function of inhibitory synapses in various disorders of the CNS. In particular we discuss how similar molecular mechanisms affecting the synaptic distribution of GABA<sub>A</sub>R and consequently the excitatory/inhibitory balance may be associated with a wide diversity of pathologies of the CNS, from psychiatric disorders to acute alterations leading to neuronal death. A better understanding of the cellular and molecular mechanisms that contribute to the impairment of GABAergic neurotransmission in these disorders, in particular the alterations in GABA<sub>A</sub>R trafficking and surface distribution, may lead to the identification of new pharmacological targets and to the development of novel therapeutic strategies.</p>
</abstract>
<kwd-group>
<kwd>GABA<sub>A</sub> receptor trafficking</kwd>
<kwd>epilepsy</kwd>
<kwd>brain ischemia</kwd>
<kwd>Alzheimer’s disease</kwd>
<kwd>Huntington’s disease</kwd>
<kwd>Parkinson’s disease</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Fundação para a Ciência e a Tecnologia<named-content content-type="fundref-id">10.13039/501100001871</named-content></funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="2"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="188"></ref-count>
<page-count count="16"></page-count>
<word-count count="14081"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>The appropriate equilibrium between excitatory and inhibitory neurotransmission, which is mainly mediated by glutamate and γ-aminobutyric acid (GABA), respectively, is necessary for the correct function of neuronal circuits in the central nervous system (CNS; Smith and Kittler, <xref ref-type="bibr" rid="B158">2010</xref>). Therefore, the control of GABAergic synaptic strength and transmission plays a crucial role in the maintenance of the excitatory/inhibitory synaptic balance (Smith and Kittler, <xref ref-type="bibr" rid="B158">2010</xref>; Mele et al., <xref ref-type="bibr" rid="B117">2016</xref>). An impairment of these mechanisms leading to neuronal hyperexcitability is a common and early event that characterizes several brain disorders (McCormick and Contreras, <xref ref-type="bibr" rid="B112">2001</xref>; Saxena and Caroni, <xref ref-type="bibr" rid="B153">2011</xref>).</p>
<p>The neurotransmitter GABA acts, in part, through activation of GABA<sub>A</sub> receptors (GABA<sub>A</sub>R), which are heteropentameric chloride channels, composed in most cases of 2α-, 2β-, and 1γ2-subunits (Rudolph and Möhler, <xref ref-type="bibr" rid="B150">2004</xref>). GABA<sub>A</sub>R with different subunit compositions have different physiological and pharmacological properties, are differentially expressed throughout the brain and are targeted to different subcellular regions (Fritschy and Mohler, <xref ref-type="bibr" rid="B48">1995</xref>; Nusser et al., <xref ref-type="bibr" rid="B132">1998b</xref>). Receptors composed of α1, α2 or α3 subunits together with β and γ subunits are benzodiazepine-sensitive and largely synaptically located, mediating most phasic inhibition in the brain (Rudolph and Möhler, <xref ref-type="bibr" rid="B150">2004</xref>). The synaptic localization of these receptors is determined by the direct interaction of the alpha subunits with the scaffold protein gephyrin (Tretter et al., <xref ref-type="bibr" rid="B170">2008</xref>, <xref ref-type="bibr" rid="B171">2011</xref>; Mukherjee et al., <xref ref-type="bibr" rid="B123">2011</xref>). On the other hand, GABA<sub>A</sub>R composed of α4, α5 or α6 subunits, together with β and δ subunits, are predominantly extrasynaptic, mediate tonic inhibition resulting mainly from synaptic “spillover” and are insensitive to benzodiazepine modulation (Brünig et al., <xref ref-type="bibr" rid="B17">2002</xref>; Glykys and Mody, <xref ref-type="bibr" rid="B58">2007</xref>; Jacob et al., <xref ref-type="bibr" rid="B78">2008</xref>). The tonic inhibition in CA1 and CA3 pyramidal neurons is mediated by α5 and δ subunit-containing GABA<sub>A</sub>R (Glykys and Mody, <xref ref-type="bibr" rid="B57">2006</xref>) that detect low, ambient concentrations of GABA in the extracellular space and desensitize slowly. Accordingly, deletion of the α5 subunit eliminates about half of the tonic currents mediated by GABA<sub>A</sub>R in hippocampal CA1 and CA3 pyramidal neurons; the remaining current was found to be mediated by GABA<sub>A</sub>R containing δ subunits (Glykys and Mody, <xref ref-type="bibr" rid="B57">2006</xref>). Moreover, studies using mice bearing a point mutation in position 105 of the GABA<sub>A</sub>R α5 subunit, which downregulates the expression of the receptors exclusively in hippocampal pyramidal neurons, showed an important role for these subunits in cognitive processes (Crestani et al., <xref ref-type="bibr" rid="B29">2002</xref>).</p>
<p>Under normal physiological conditions GABA<sub>A</sub>R respond to the binding of GABA by opening an integral chloride channel and allowing chloride to enter the neuron. The result is a membrane hyperpolarization and neuronal inhibition. This mechanism of inhibition by GABA<sub>A</sub>R depends on the electrochemical potential for chloride. Therefore changes of the intracellular Cl<sup>−</sup> concentration ([Cl<sup>−</sup>]<sub>i</sub>) may regulate the response to the activation of GABA<sub>A</sub>R (Jedlicka et al., <xref ref-type="bibr" rid="B81">2011</xref>). For example, in immature neurons GABA<sub>A</sub>R are mostly excitatory due to the fact that the intracellular chloride concentration is above the equilibrium. Maturation of the CNS is accompanied by a decrease of neuronal [Cl<sup>−</sup>]<sub>i</sub>, which accounts for the hyperpolarizing effect of the receptor (Watanabe and Fukuda, <xref ref-type="bibr" rid="B182">2015</xref>).</p>
<p>Neuronal [Cl<sup>−</sup>]<sub>i</sub> is mostly regulated by two chloride cotransporters, KCC2 (K<sup>+</sup>-Cl<sup>−</sup> cotransporter; KCC type 2) and NKCC1 (the Na<sup>+</sup>-K<sup>+</sup>-2Cl<sup>−</sup> cotransporter type 1; Russell, <xref ref-type="bibr" rid="B151">2000</xref>; Blaesse et al., <xref ref-type="bibr" rid="B12">2009</xref>). KCC2 expression is neuronal specific and under normal physiological conditions the transporter extrudes Cl<sup>−</sup> out of the cell. NKCC1 is present in a variety of cells and generally loads cells with Cl<sup>−</sup>. Furthermore, the relative expression pattern of the two transporters differs across development (Russell, <xref ref-type="bibr" rid="B151">2000</xref>; Ben-Ari, <xref ref-type="bibr" rid="B10">2002</xref>). The NKCC1 transporter is more expressed earlier in development than KCC2, and this accounts for the high [Cl<sup>−</sup>]<sub>i</sub> observed in immature neurons. In the mature brain, the increased abundance of KCC2 contributes to a lower [Cl<sup>−</sup>]<sub>i</sub> when compared with the extracellular concentration, favoring the influx of Cl<sup>−</sup> through the GABA<sub>A</sub>R channel and consequent membrane hyperpolarization upon activation of the receptors (Kaila et al., <xref ref-type="bibr" rid="B85">2014</xref>).</p>
<p>The activity of GABA<sub>A</sub>R is also regulated by “cross-talk” with other receptors (Shrivastava et al., <xref ref-type="bibr" rid="B156">2011a</xref>). Since GABA<sub>A</sub>R can be found in heterologous synapses (Nusser et al., <xref ref-type="bibr" rid="B133">1996</xref>; Renner et al., <xref ref-type="bibr" rid="B146">2012</xref>; de Luca et al., <xref ref-type="bibr" rid="B34">2017</xref>), such receptor cross-talk may be mediated by a direct interaction with other receptors or through activation of intracellular signaling pathways. For example, GABA<sub>A</sub>Rs have been demonstrated to heteromerize with GABA<sub>B</sub>R (Balasubramanian et al., <xref ref-type="bibr" rid="B5">2004</xref>), dopamine D5 receptors (Liu et al., <xref ref-type="bibr" rid="B300">2000</xref>), purinergic P2X receptors (Jo et al., <xref ref-type="bibr" rid="B83">2011</xref>; Shrivastava et al., <xref ref-type="bibr" rid="B157">2011b</xref>), nicotinic acetylcholine receptors (Lee et al., <xref ref-type="bibr" rid="B100">2010</xref>) and adenosine A<sub>1</sub> receptors (Hu and Li, <xref ref-type="bibr" rid="B72">1997</xref>). In particular, the cross-talk between GABA<sub>B</sub>R/GABA<sub>A</sub>R may contribute to their regulation at pre- and postsynaptic levels. For instance, a direct interaction of GABA<sub>B1</sub> subunits with γ2S subunits of GABA<sub>A</sub>R was observed in the rat brain, and co-expression of GABA<sub>B1</sub> subunits with GABA<sub>A</sub>R increases the inhibitory responses mediated by the latter receptors (Balasubramanian et al., <xref ref-type="bibr" rid="B5">2004</xref>). Of particular interest is the NMDA receptor (NMDAR) mediated modulation of GABA<sub>A</sub>R. It has been demonstrated that activation of NMDAR downregulates GABA<sub>A</sub>R function due to calcium dependent activation of phosphatase 2B/calcineurin followed by dephosphorylation of GABA<sub>A</sub>R (Stelzer and Shi, <xref ref-type="bibr" rid="B164">1994</xref>; Chen and Wong, <xref ref-type="bibr" rid="B21">1995</xref>; Marsden et al., <xref ref-type="bibr" rid="B109">2007</xref>; Bannai et al., <xref ref-type="bibr" rid="B6">2009</xref>). A recent study showed that GABA<sub>A</sub>Rs are trapped at glutamatergic synapses in response to glutamatergic stimulation, thereby limiting GABA<sub>A</sub>R inter-synaptic diffusion (de Luca et al., <xref ref-type="bibr" rid="B34">2017</xref>). The evidence that a hetero-synaptic interaction is modulated by neuronal activity suggests that cross-talk between GABA<sub>A</sub>R and other receptors may be considered a mechanism for tuning inhibition in the CNS.</p>
<p>Deficits in the functional expression of GABA<sub>A</sub>R have been implicated in the pathogenesis of several neurological and psychiatric diseases (Schwartz-Bloom and Sah, <xref ref-type="bibr" rid="B302">2001</xref>; Rudolph and Knoflach, <xref ref-type="bibr" rid="B301">2011</xref>; Kaila et al., <xref ref-type="bibr" rid="B85">2014</xref>). GABA<sub>A</sub>R are assembled within the endoplasmic (ER) and are then transported to the Golgi. In the ER, unassembled receptor subunits are subjected to poly-ubiquitination that targets them for proteasomal degradation (Kittler et al., <xref ref-type="bibr" rid="B93">2002</xref>), a phenomenon that is dependent on the level of neuronal activity (Saliba et al., <xref ref-type="bibr" rid="B152">2007</xref>). This process is negatively regulated by Plic-1 (the protein that links integrin-associated protein with the cytoskeleton-1; Bedford et al., <xref ref-type="bibr" rid="B9">2001</xref>), which binds directly to the α- and β-subunits of the receptor, prolonging their residence times in the ER (<xref ref-type="fig" rid="F1">Figure 1</xref>). Inside the Golgi, GABA<sub>A</sub>R receptors bind to GABA<sub>A</sub>R associated protein (GABARAP)/N-ethylmaleimide-sensitive factor (NSF) complexes, facilitating their transport to the plasma membrane (Leil et al., <xref ref-type="bibr" rid="B101">2004</xref>). This mechanism mediates the increase in the exocytosis of GABA<sub>A</sub>R observed upon stimulation of cultured hippocampal neurons with N-Methyl-D-aspartate (NMDA; Marsden et al., <xref ref-type="bibr" rid="B109">2007</xref>). The delivery of GABA<sub>A</sub>R to the plasma membrane is regulated by Golgi-specific DHHC (Asp-His-His-Cys) zinc finger protein (GODZ), a Golgi resident palmitoyltransferase responsible for the palmitoylation of γ subunits. GODZ interacts with the GABA<sub>A</sub>R γ2 subunit recognizing a 14-amino acid cysteine-rich domain conserved in the intracellular domain of γ1–3 subunits, NH<sub>2</sub>-terminal to the GABARAP binding site (Rathenberg et al., <xref ref-type="bibr" rid="B144">2004</xref>). The γ2 subunit is palmitoylated at all four cysteines within the GODZ binding domain (Rathenberg et al., <xref ref-type="bibr" rid="B144">2004</xref>; Vithlani et al., <xref ref-type="bibr" rid="B179">2011</xref>). The ADP ribosylation factor (Arf) guanine nucleotide exchange factor (GEF) Big2 (brefeldin A-inhibited GDP/GTP exchange factor 2) also plays a role in the delivery of GABA<sub>A</sub>R from the Golgi to the plasma membrane by promoting the budding and trafficking of vesicles from this compartment (Charych et al., <xref ref-type="bibr" rid="B20">2004b</xref>). This protein interacts with the intracellular loop of all GABA<sub>A</sub>R β2 subunits (Charych et al., <xref ref-type="bibr" rid="B20">2004b</xref>). Additional proteins important in the trafficking of GABA<sub>A</sub>R from the Golgi to the plasma membrane are the glutamate receptor-interacting protein (GRIP; Charych et al., <xref ref-type="bibr" rid="B20">2004b</xref>; Kittler et al., <xref ref-type="bibr" rid="B89">2004a</xref>), the phospholipase C-related catalytically inactive proteins 1 and 2 (PRIP1/2; Kanematsu et al., <xref ref-type="bibr" rid="B86">2002</xref>; Uji et al., <xref ref-type="bibr" rid="B174">2002</xref>), the GABA<sub>A</sub>R-interacting factor (GRIF-1; Beck et al., <xref ref-type="bibr" rid="B8">2002</xref>) and Maf1 interacting coiled-coil protein (Macoco; Smith et al., <xref ref-type="bibr" rid="B161">2010</xref>). The insertion into the membrane of the vesicles containing GABA<sub>A</sub>R also depends on SNAP23-syntaxin1A/B-VAMP2 complexes (Gu et al., <xref ref-type="bibr" rid="B62">2016</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p>GABA<sub>A</sub> receptor (GABA<sub>A</sub>R) trafficking under physiologic condition. (1) GABA<sub>A</sub>R are assembled in the ER. (2) In the ER, unassembled receptor subunits are subjected to poly-ubiquitination and targeted for proteasomal degradation. (3) GABA<sub>A</sub>R transport to the Golgi is a process negatively regulated by Plic-1. Inside the Golgi, GABA<sub>A</sub>R bind to GABA<sub>A</sub>R associated protein (GABARAP)/N-ethylmaleimide-sensitive factor (NSF) complex that facilitates their transport to the plasma membrane. The delivery of GABA<sub>A</sub>R to the plasma membrane is also regulated by GODZ, Big2, glutamate receptor-interacting protein (GRIP) and PRIP. (4) At the plasma membrane, GABA<sub>A</sub>R quickly exchange between synaptic and extrasynaptic locations, and the accumulation of the receptor at the inhibitory synapses is regulated by its scaffold protein gephyrin. (5) The phosphorylation of β3 or γ2 GABA<sub>A</sub>R subunits on their intracellular loop negatively regulates GABA<sub>A</sub>R internalization. (6) The process of GABA<sub>A</sub>R endocytosis is AP2/clathrin/dynamin-mediated. (7) Most internalized GABA<sub>A</sub>R are rapidly recycled back to the plasma membrane by a mechanism dependent of the interaction with huntingtin-associated protein 1 (HAP1). (8) The non-recycled GABA<sub>A</sub>R are targeted for lysosomal degradation.</p>
</caption>
<graphic xlink:href="fncel-13-00077-g0001"></graphic>
</fig>
<p>Once in the membrane, GABA<sub>A</sub>R are very dynamic, exchanging between synaptic and extrasynaptic locations (Jacob et al., <xref ref-type="bibr" rid="B77">2005</xref>; Thomas et al., <xref ref-type="bibr" rid="B168">2005</xref>; Bogdanov et al., <xref ref-type="bibr" rid="B14">2006</xref>), being the accumulation of the receptors at the inhibitory synapses regulated by the scaffold protein gephyrin (Fritschy et al., <xref ref-type="bibr" rid="B49">2008</xref>; Tyagarajan and Fritschy, <xref ref-type="bibr" rid="B173">2014</xref>). Gephyrin recruitment to inhibitory synapses is a fundamental phenomenon for their long-term potentiation (iLTP). Studies using a chemical protocol to induce iLTP in cultured hippocampal neurons, consisting in a moderate activation of NMDARs, showed an increased synaptic clustering of GABA<sub>A</sub>R by a mechanism involving a CaMKII-dependent phosphorylation of GABA<sub>A</sub>R β3 subunits on S383 (Petrini et al., <xref ref-type="bibr" rid="B138">2014</xref>). Potentiation of inhibitory synapses in the same model was found to be mediated by recruitment of gephyrin from extrasynaptic regions, downstream of GABA<sub>A</sub>R phosphorylation, as shown by single-particle tracking (SPT) analysis (Petrini et al., <xref ref-type="bibr" rid="B138">2014</xref>). Recent studies using single-molecule super-resolution imaging with a novel clustering analysis, showed a rearrangement of synaptic gephyrin molecules during iLTP, with the formation of gephyrin nanodomains within the synaptic area (Pennacchietti et al., <xref ref-type="bibr" rid="B137">2017</xref>).</p>
<p>GABA<sub>A</sub>R are in a continuous cycle between the plasma membrane and the intracellular compartments (Jacob et al., <xref ref-type="bibr" rid="B78">2008</xref>; Mele et al., <xref ref-type="bibr" rid="B117">2016</xref>). Regulation of the total GABA<sub>A</sub>R surface expression plays a key role in the control of the postsynaptic receptor pool size and the strength of synaptic inhibition (Mele et al., <xref ref-type="bibr" rid="B117">2016</xref>). The process of GABA<sub>A</sub>R endocytosis occurs mainly <italic>via</italic> clathrin- and dynamin-dependent mechanisms upon interaction of GABA<sub>A</sub>R β and γ subunits with the adaptor protein 2 (AP2) clathrin adaptor protein complex (Kittler et al., <xref ref-type="bibr" rid="B92">2000</xref>, <xref ref-type="bibr" rid="B90">2005</xref>, <xref ref-type="bibr" rid="B91">2008</xref>). In the brain, GABA<sub>A</sub>R interact with AP2 through a direct binding of the β1–3 and γ2 GABA<sub>A</sub>R subunits (Kittler et al., <xref ref-type="bibr" rid="B92">2000</xref>). The first sequence motif important for AP2/clathrin/dynamin-mediated endocytosis of GABA<sub>A</sub>R was identified in an heterologous system and corresponds to a di-leucine motif present in β subunits (Herring et al., <xref ref-type="bibr" rid="B67">2003</xref>, <xref ref-type="bibr" rid="B66">2005</xref>). Additional studies performed in neurons, identified an amino acid sequence motif (KTHLRRRSSQLK in the β3 subunit), which includes a major phosphorylation site conserved in the cytoplasmic loop region of β1–3 subunits (Ser<sup>408</sup>, Ser<sup>409</sup> in β3), as an important motif for AP2/clathrin/dynamin-mediated GABA<sub>A</sub>R internalization (Kittler et al., <xref ref-type="bibr" rid="B90">2005</xref>, <xref ref-type="bibr" rid="B91">2008</xref>). This motif also contains the major sites of phosphorylation by cAMP-dependent protein kinase A (PKA) and calcium/phospholipid-dependent PKC within this class of receptor subunits: Ser<sup>409</sup> in β1, Ser<sup>410</sup> in β2, and Ser<sup>408/9</sup> in β3 (McDonald et al., <xref ref-type="bibr" rid="B114">1998</xref>; Brandon et al., <xref ref-type="bibr" rid="B15">2002</xref>, <xref ref-type="bibr" rid="B16">2003</xref>; Kittler et al., <xref ref-type="bibr" rid="B90">2005</xref>; Smith et al., <xref ref-type="bibr" rid="B159">2008</xref>). Furthermore, a sequence of three arginine residues (<sup>405</sup>RRR<sup>407</sup>) was identified within the β3 subunit that is responsible for the interaction of GABA<sub>A</sub>R with AP2 and in the stabilization of the receptors at dendritic endocytic zones where they are internalized (Smith et al., <xref ref-type="bibr" rid="B160">2012</xref>). The GABA<sub>A</sub>R internalization rate is negatively regulated by phosphorylation of β3 or γ2 GABA<sub>A</sub>R subunits on their intracellular loop. Thus, NMDAR signaling is known to control the stability of synaptic GABA<sub>A</sub>R <italic>via</italic> calcineurin-mediated dephosphorylation of the receptors (Muir et al., <xref ref-type="bibr" rid="B122">2010</xref>). Moreover, a tyrosine-based AP2-μ2 adaptin-binding motif (Y<sup>365</sup>GY<sup>367</sup>ECL) was identified in the GABA<sub>A</sub>R γ2 subunit, which is also conserved in the γ1 and γ3 subunits (Moss et al., <xref ref-type="bibr" rid="B121">1995</xref>; Kittler et al., <xref ref-type="bibr" rid="B91">2008</xref>). These tyrosine residues are the major sites for phosphorylation by Fyn and Src kinases (Nishikawa et al., <xref ref-type="bibr" rid="B129">2002</xref>; Jacob et al., <xref ref-type="bibr" rid="B77">2005</xref>; Bogdanov et al., <xref ref-type="bibr" rid="B14">2006</xref>), and their phosphorylation reduces AP2 binding (Kittler et al., <xref ref-type="bibr" rid="B91">2008</xref>).</p>
<p>The internalized GABA<sub>A</sub>R may be rapidly recycled back to the neuronal plasma membrane or targeted for lysosomal degradation. The destiny of receptors following endocytosis is determinant for the regulation of surface/synaptic receptor abundance. The interaction of GABA<sub>A</sub>R β1–3 subunits with huntingtin-associated protein 1 (HAP1) determines whether endocytosed GABA<sub>A</sub>R are recycled (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). HAP1 is a GABA<sub>A</sub>R associated protein that binds the intracellular loop of β subunits <italic>in vitro</italic> and <italic>in vivo</italic> (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). Overexpression of HAP1 in neurons inhibits GABA<sub>A</sub>R degradation and consequently increases receptor recycling (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). Furthermore, HAP1 overexpression was shown to increase surface levels of GABA<sub>A</sub>R and miniature inhibitory postsynaptic current (mIPSC) amplitude in cultured hippocampal neurons (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>).</p>
<p>The balance between the insertion, lateral diffusion, internalization and recycling of GABA<sub>A</sub>R in the neuronal plasma membrane determines the strength of GABAergic synapses. Defects in GABA<sub>A</sub>R trafficking have been reported as triggers of GABAergic dysfunction in a number of brain pathological conditions (Hines et al., <xref ref-type="bibr" rid="B69">2012</xref>). The following sections will address the alterations in GABA<sub>A</sub>R trafficking, in acute brain disorders, as well as in neuropsychiatric and neurodegenerative diseases (<xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p>Alterations of GABA<sub>A</sub>R trafficking in brain disorders. Deficits in GABA<sub>A</sub>R trafficking have been reported in different pathological conditions in the central nervous system (CNS). (1) Reduced synaptic clustering of GABA<sub>A</sub>R has been observed in epilepsy, ischemia, autism spectrum disorders (ASDs) and Alzheimer’s disease (AD). (2) Increased dephosphorylation of GABA<sub>A</sub>R β3 subunit on serine residues 408/9 (Ser<sup>408/409</sup>) has been reported in epilepsy, ischemic condition and ASD. (3) An increase in AP2/clathrin/dynamin-mediated endocytosis of GABA<sub>A</sub>R occurs in epileptic conditions, ischemia, ASD and AD. (4) Impairment in GABA<sub>A</sub>R recycling has been shown in ischemic conditions and in Huntington’s disease (HD). (5) Enhanced lysosomal degradation of GABA<sub>A</sub>R due to ubiquitination was detected after an ischemic insult.</p>
</caption>
<graphic xlink:href="fncel-13-00077-g0002"></graphic>
</fig>
</sec>
<sec id="s2">
<title>Alterations in the Rate of Constitutive Degradation and on the Trafficking of GABA<sub>A</sub>R in Epilepsy</title>
<p>Epilepsy is a chronic disorder of the brain characterized by the presence of recurrent spontaneous seizures. The disease affects approximately 65 million people worldwide, from all ages and both genders (Jacobs et al., <xref ref-type="bibr" rid="B79">2009</xref>; Hesdorffer et al., <xref ref-type="bibr" rid="B68">2013</xref>). In temporal lobe epilepsy, the most common form of partial epilepsy in humans, an initial insult is followed by a seizure-free period before the development of spontaneous seizures. The process by which the brain become hyperexcitable and prone to generate seizures is defined as epileptogenesis (Sharma et al., <xref ref-type="bibr" rid="B155">2007</xref>; Curia et al., <xref ref-type="bibr" rid="B31">2008</xref>). During the latent (seizure-free) period there is a complex reorganization of neuronal networks, which has been characterized in more detail in the hippocampus (Goldberg and Coulter, <xref ref-type="bibr" rid="B59">2013</xref>). An increase in neuronal excitability may contribute to the genesis and/or propagation of epileptic seizures, and several cellular and molecular changes are thought to be involved in the development of spontaneous seizures following a brain insult (Loscher and Brandt, <xref ref-type="bibr" rid="B108">2010</xref>; Goldberg and Coulter, <xref ref-type="bibr" rid="B59">2013</xref>; Staley, <xref ref-type="bibr" rid="B162">2015</xref>).</p>
<p>Studies in animal models have shown that the pathophysiology related with the appearance of seizures is associated with a dysfunction of GABAergic neurotransmission (El-Hassar et al., <xref ref-type="bibr" rid="B42">2007</xref>). Accordingly, several antiepileptic drugs act as agonists of GABA<sub>A</sub>R (Czuczwar and Patsalos, <xref ref-type="bibr" rid="B32">2001</xref>) and a dysfunction of GABA<sub>A</sub>R has been proposed to be involved in the etiology of epilepsy. In fact, mutations or genetic variants of the genes encoding the α1, α6, β2, β3, γ2, or δ subunits have been associated with human epilepsy (reviewed by Hirose, <xref ref-type="bibr" rid="B70">2014</xref>). Also, mutations in GABA<sub>A</sub>R that enhance the constitutive ER-associated degradation (ERAD) of the receptors have been associated with genetically determined epilepsies, as well as, with idiopathic generalized epilepsies (Cossette et al., <xref ref-type="bibr" rid="B25">2002</xref>; Huang et al., <xref ref-type="bibr" rid="B73">2014</xref>). Furthermore, multiple GABA<sub>A</sub>R mutations associated with epilepsy result in the abnormal trafficking of the receptors (Kang et al., <xref ref-type="bibr" rid="B87">2015</xref>), perturbing their expression on the plasma membrane and synaptic clustering (Han et al., <xref ref-type="bibr" rid="B64">2015</xref>; Huang et al., <xref ref-type="bibr" rid="B74">2017</xref>; Ishii et al., <xref ref-type="bibr" rid="B76">2017</xref>).</p>
<p>Among genetic epilepsies displaying abnormal GABAergic neurotransmission, a group of pediatric monogenic epilepsies was characterized in patients with the Dravet and Rett syndromes (Ali Rodriguez et al., <xref ref-type="bibr" rid="B1">2018</xref>; Gataullina et al., <xref ref-type="bibr" rid="B54">2019</xref>). These disorders are associated with neurodevelopmental complications, and autism spectrum disorders (ASD)-like features are common in patients with both syndromes, suggesting a link between epilepsy and ASD (Ali Rodriguez et al., <xref ref-type="bibr" rid="B1">2018</xref>). In fact, epilepsy is quite common in patients with ASD and therefore the association between epilepsy and autism is receiving growing interest (Deykin and MacMahon, <xref ref-type="bibr" rid="B36">1979</xref>; Olsson et al., <xref ref-type="bibr" rid="B134">1988</xref>; Galanopoulou et al., <xref ref-type="bibr" rid="B50">2000</xref>; Giovanardi Rossi et al., <xref ref-type="bibr" rid="B56">2000</xref>; Besag, <xref ref-type="bibr" rid="B11">2004</xref>; Hughes and Melyn, <xref ref-type="bibr" rid="B75">2005</xref>; Kosinovsky et al., <xref ref-type="bibr" rid="B97">2005</xref>). In addition to the most common mutation in the SCN1A gene affecting the α1 subunit of voltage-gated sodium channels (Wu et al., <xref ref-type="bibr" rid="B183">2015</xref>), Dravet syndrome may also result from mutations in genes that alter GABAergic transmission, such as GABRA1, GABRB2, GABRB3, and GABRG2, encoding the corresponding subunits of GABA<sub>A</sub>R (α1, β1, β2 and γ2 subunits, respectively). Moreover, a recent study identified a de novo heterozygous missense mutation in GPHN, which encodes for gephyrin, in a patient with Dravet-like syndrome (Dejanovic et al., <xref ref-type="bibr" rid="B35">2017</xref>). Human mutations in the protocadherin-19 (PCDH19) gene, which encodes for the PCDH19 protein, also cause early infantile epileptic encephalopathy, associated with intellectual disability and autistic features (Kolc et al., <xref ref-type="bibr" rid="B96">2019</xref>), similar to Dravet syndrome. PCDH19 cytoplasmic region binds to the α subunits of GABA<sub>A</sub>R thereby regulating the receptor surface expression, suggesting that PCDH19 might be involved in the regulation of GABA<sub>A</sub>R intracellular trafficking (Bassani et al., <xref ref-type="bibr" rid="B7">2018</xref>). Furthermore, PCDH19 downregulation in hippocampal neurons causes a reduced frequency of mIPSCs (Bassani et al., <xref ref-type="bibr" rid="B7">2018</xref>).</p>
<p>The primary cause of Rett syndrome is a mutation of the gene encoding the transcriptional repressor methyl-CpG-binding protein 2 (MeCP2; Kozinetz et al., <xref ref-type="bibr" rid="B98">1993</xref>). Between 60 and 80% of females with Rett syndrome suffer from epilepsy (Vignoli et al., <xref ref-type="bibr" rid="B178">2017</xref>). Studies performed in the Mecp2 KO animal model of Rett syndrome, showed a dramatic loss of GABAergic neurons (Chao et al., <xref ref-type="bibr" rid="B18">2010</xref>). Moreover, recent evidence demonstrated that Mecp2 targets KCC2, and neurons differentiated from induced pluripotent stem cells from patients with Rett syndrome showed a reduced expression of KCC2 and a delayed switch in the excitatory to inhibitory responses to GABA during development (Tang et al., <xref ref-type="bibr" rid="B165">2016</xref>).</p>
<p>The major problem in the therapy of status epilepticus (SE), and recurrent epileptiform discharges, is the time-dependent pharmacoresistance; about 30% of the patients become resistant to the treatment (Regesta and Tanganelli, <xref ref-type="bibr" rid="B145">1999</xref>; French, <xref ref-type="bibr" rid="B46">2007</xref>). A potential mechanism accounting for the impairment of inhibitory neurotransmission, characteristic of SE, and for the development of pharmacoresistance to benzodiazepines (De Koninck, <xref ref-type="bibr" rid="B33">2007</xref>), is a reduction in the availability of functional GABA<sub>A</sub>Rs associated with the plasma membrane, which may arise from an altered pattern of receptor trafficking (<xref ref-type="fig" rid="F2">Figure 2</xref>). Accordingly, <italic>in vitro</italic> studies performed in hippocampal neurons exposed to a medium lacking Mg<sup>2+</sup>, to induce epileptiform discharges, showed a reduction of about 50% in the surface expression of GABA<sub>A</sub>R after 1 h of SE, as demonstrated by a biotinylation assay (Cho et al., <xref ref-type="bibr" rid="B24">2017</xref>). Furthermore, experiments using cultured hippocampal neurons incubated in a medium lacking Mg<sup>2+</sup>, an <italic>in vitro</italic> model of SE, showed a reduction in the surface stability of GABA<sub>A</sub>R as determined by live-cell imaging of SE pHluorin (SEP)-tagged α<sub>2</sub> subunits. The observed decrease in the surface expression of GABA<sub>A</sub>R was mediated by activation of NMDARs for glutamate and was sensitive to inhibition of the phosphatase calcineurin (Eckel et al., <xref ref-type="bibr" rid="B41">2015</xref>). Additional studies using the same <italic>in vitro</italic> model of SE combined with electrophysiological and cellular imaging techniques, showed that prolonged epileptiform bursting leads to a reduction of GABA-mediated synaptic inhibition; the constitutive internalization of GABA<sub>A</sub>R accelerated by the increased neuronal activity was associated with seizure activity. Moreover, inhibition of neuronal activity reduced the effect of SE on the rate of GABA<sub>A</sub>R internalization as well as the downstream reduction in the surface expression of the receptors that may contribute to the downregulation of inhibitory neurotransmission observed during seizures (Goodkin et al., <xref ref-type="bibr" rid="B61">2005</xref>). This model is supported by evidence obtained in <italic>in vivo</italic> studies using the lithium-pilocarpine model of TLE, which showed a reduction in the amplitude of mIPSCs mediated by postsynaptic GABA<sub>A</sub>R when tested in dentate gyrus granule cells (Naylor et al., <xref ref-type="bibr" rid="B127">2005</xref>). In contrast, the amplitude of extrasynaptic GABA<sub>A</sub>R tonic currents was increased during SE (Naylor et al., <xref ref-type="bibr" rid="B127">2005</xref>). These results also suggests a possible increase in extracellular GABA concentration during SE, which may be coupled to an upregulation of extrasynaptic tonic currents, while synaptic currents may be decreased under the same conditions due to desensitization and internalization of GABA<sub>A</sub>R (Naylor et al., <xref ref-type="bibr" rid="B127">2005</xref>). In fact, inhibition of GABA<sub>A</sub>R endocytosis in epileptic cultures resulted in both a recovery of the levels of membrane associated GABA<sub>A</sub>R and a total blockade of spontaneous recurrent epileptiform discharges (Blair et al., <xref ref-type="bibr" rid="B13">2004</xref>).</p>
<p>In accordance with the role of GABA<sub>A</sub>R phosphorylation in the regulation of their surface expression (see above), SE reduces PKC-dependent phosphorylation of GABA<sub>A</sub>R β3 subunit on the serine residues 408/9 (Ser<sup>408/409</sup>; Terunuma et al., <xref ref-type="bibr" rid="B166">2008</xref>). These residues contain a binding motif for the clathrin AP AP2, being a critical regulator of GABA<sub>A</sub>R endocytosis (Nakamura et al., <xref ref-type="bibr" rid="B126">2015</xref>). Pharmacological activation of PKC or the specific blockade of GABA<sub>A</sub>R binding to AP2, during SE, restores the surface expression of the receptors, re-establishing the efficacy of synaptic inhibition (Terunuma et al., <xref ref-type="bibr" rid="B166">2008</xref>).</p>
<p>The proper trafficking of GABA<sub>A</sub>R required to maintain the number and localization of the receptors at the neuronal surface is also dependent on the function of different proteins that interact with GABA<sub>A</sub>R directly or through adaptor proteins linked with microtubules (Mele et al., <xref ref-type="bibr" rid="B117">2016</xref>). The expression of key scaffolding proteins associated with GABA<sub>A</sub>R is altered during epileptogenesis. For example, SE downregulates the expression of gephyrin and GRIP in the hippocampal CA1 region 4–8 days after the insult (pilocarpine injection; González et al., <xref ref-type="bibr" rid="B60">2013</xref>). These alterations are correlated with changes in the plasma membrane expression and assembly of GABA<sub>A</sub>R (González et al., <xref ref-type="bibr" rid="B60">2013</xref>). To what extent the downregulation of GRIP contributes to the observed reduction in the surface expression of GABA<sub>A</sub>R remains to be investigated. In fact, GRIP interacts with GABARAP (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>) and is expressed at inhibitory postsynapses (Dong et al., <xref ref-type="bibr" rid="B39">1999</xref>; Charych et al., <xref ref-type="bibr" rid="B19">2004a</xref>; Li et al., <xref ref-type="bibr" rid="B103">2005</xref>). Therefore, the SE-induced decrease in GRIP protein levels may impair the GABARAP-mediated delivery of GABA<sub>A</sub>R to the plasma membrane (Marsden et al., <xref ref-type="bibr" rid="B109">2007</xref>).</p>
<p>Alterations in gephyrin clustering and expression during epileptogenesis were also detected in the hippocampus and in the cerebral cortex (Thind et al., <xref ref-type="bibr" rid="B167">2010</xref>; Fang et al., <xref ref-type="bibr" rid="B43">2011</xref>). The epileptogenic period is characterized by a reduction in the number of gephyrin puncta and GABAergic synapses in dentate gyrus, while an increased number of gephyrin clusters was detected during the chronic period (Thind et al., <xref ref-type="bibr" rid="B167">2010</xref>). Moreover, studies performed in the neocortex showed that gephyrin expression gradually decreases during the epileptogenic period and returns to basal levels during the chronic phase (Fang et al., <xref ref-type="bibr" rid="B43">2011</xref>). Thus, gephyrin downregulation may contribute to the instability of GABA<sub>A</sub>R clustering, amplifying the deficit in GABAergic neurotransmission observed in epileptic condition.</p>
<p>The ezrin/radixin/moesin (ERM) family protein radixin acts a scaffold to anchor α5βγ2 GABA<sub>A</sub>R to the actin cytoskeleton at extrasynaptic sites (Loebrich et al., <xref ref-type="bibr" rid="B107">2006</xref>). This interaction is regulated by an activity-dependent manner through the RhoA-ROCK pathway (Hausrat et al., <xref ref-type="bibr" rid="B65">2015</xref>). The dissociation of the receptors from the radixin anchor allows the lateral diffusion of GABA<sub>A</sub>R to increase their synaptic expression (Hausrat et al., <xref ref-type="bibr" rid="B65">2015</xref>). However, whether this type of mechanism regulates the surface expression of GABA<sub>A</sub>R containing α5 subunits remains to be investigated.</p>
<p>Recent evidence indicates that alterations in chloride homeostasis may also contribute to the impairment of the GABA inhibitory activity (Rivera et al., <xref ref-type="bibr" rid="B147">2004</xref>). These alterations have been attributed to a downregulation of the K<sup>+</sup>-Cl<sup>−</sup> cotransporter KCC2. The resulting increase in the intracellular Cl<sup>−</sup> concentration may account for the positive shift of the GABA<sub>A</sub>R reversal potential, and the consequent depolarizing effects of GABA, observed in hippocampal slices exposed to conditions mimicking status epilepticus (Coull et al., <xref ref-type="bibr" rid="B28">2003</xref>). Interestingly, two independent studies reported that rare variants of KCC2 confer an increased risk of epilepsy in humans (Kahle et al., <xref ref-type="bibr" rid="B84">2014</xref>; Puskarjov et al., <xref ref-type="bibr" rid="B142">2014</xref>). However, whether the SE-induced alteration in GABA<sub>A</sub>R trafficking depends on the alteration in Cl<sup>–</sup> gradient was not yet confirmed.</p>
<p>Taken together, the studies mentioned above indicate that during seizures, the persistent cell firing and GABA release may lead to the extracellular accumulation of GABA, causing desensitization and internalization of postsynaptic GABA<sub>A</sub>R. Moreover, alterations of scaffolding proteins associated with GABA<sub>A</sub>R, mainly gephyrin, contribute to the ultimate failure of inhibition observed in epilepsy. These mechanisms could account for the maintenance of recurrent seizure activity and benzodiazepine pharmacoresistance.</p>
</sec>
<sec id="s3">
<title>A Decrease in GABA<sub>A</sub>R Anchoring at the Synapse and in Receptor Recycling Impair Inhibitory Synapses in Brain Ischemia</title>
<p>Cerebral ischemia is a pathological condition caused by insufficient blood supply to the brain, which leads to an increase in glutamatergic neurotransmission coupled to excitotoxic neuronal death. The down-regulation of GABAergic synapses in brain ischemia resulting from GABA<sub>A</sub>R desensitization (Gyenes et al., <xref ref-type="bibr" rid="B63">1994</xref>) and a reduction of cell surface density of GABA<sub>A</sub>R (Nusser et al., <xref ref-type="bibr" rid="B130">1997</xref>, <xref ref-type="bibr" rid="B131">1998a</xref>), is one of the major factors contributing to excitotoxicity (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>).</p>
<p>One of the first direct evidence suggesting that ischemic insults decrease the cell surface expression of GABA<sub>A</sub>R through an increase in receptor internalization (<xref ref-type="fig" rid="F2">Figure 2</xref>) came from <italic>in vitro</italic> studies using ELISA, as a cell surface receptor assay (Mielke and Wang, <xref ref-type="bibr" rid="B120">2005</xref>). These studies showed that transient incubation of cultured cortical neurons in the absence of oxygen and glucose to mimic global ischemia decreases cell surface GABA<sub>A</sub>R without altering the total expression of receptors. In fact, inhibition of receptor endocytosis with hypertonic sucrose treatment prevented receptor internalization. In the same study, the authors suggested that GABA<sub>A</sub>R internalization could contribute to neuronal death (Mielke and Wang, <xref ref-type="bibr" rid="B120">2005</xref>). Similarly, studies using quantitative membrane protein biotinylation assays and immunocytochemistry confirmed that the abundance of plasma membrane-associated GABA<sub>A</sub>R was significantly decreased in cortical and hippocampal neurons exposed to oxygen and glucose deprivation (OGD). In this set of experiments the activation of phosphatidylinositol 3-kinase/Akt-dependent signaling pathway, through PTEN downregulation, was shown to protect neurons from the toxic effects of OGD by preventing the reduction in the surface expression of GABA<sub>A</sub>R (Smith et al., <xref ref-type="bibr" rid="B160">2012</xref>). Results obtained with antibody feeding assay also showed that OGD-induces the internalization of GABA<sub>A</sub>R-α1 and β3 subunits in cultured hippocampal neurons by a dynamin-dependent mechanism (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>). Additionally, it was reported that the down-modulation of GABA<sub>A</sub>R from dendritic clusters during OGD is dependent on the AP2 pathway for cell surface removal of the receptors. Moreover, blockade of this pathway reduced the neuronal death induced by OGD (Kittler et al., <xref ref-type="bibr" rid="B91">2008</xref>).</p>
<p>The interaction between β3-subunit and AP2 seems to be critical for GABA<sub>A</sub>R reduction in synapses during ischemic insult (Smith et al., <xref ref-type="bibr" rid="B160">2012</xref>). The identification of the intracellular domains (ICD) region of the β3-subunit that mediates the interaction with the clathrin adaptor AP2 also revealed the presence of three arginine residues (<sup>405</sup>RRR<sup>407</sup>) within this binding motif that are essential for the interaction with μ2–AP2; mutation of these residues impairs receptor recruitment to clathrin-coated pits, significantly reducing receptor endocytosis (Smith et al., <xref ref-type="bibr" rid="B160">2012</xref>). Studies performed with a β3-subunit RRR motif mutant with a deficient AP2 binding site showed that the acute loss of synaptic GABA<sub>A</sub>R during OGD is mediated by an AP2/β3 interaction. Furthermore, blocking the internalization of GABA<sub>A</sub>R using a peptide competing with β3 for the binding to AP2 reduces OGD-induced cell death (Smith et al., <xref ref-type="bibr" rid="B160">2012</xref>).</p>
<p>Interestingly, the β3-subunit RRR motif is located adjacent to a phosphorylation site, Ser<sup>408</sup>/Ser<sup>409</sup>, which is known to negatively regulate the internalization of the receptor when phosphorylated (Kittler et al., <xref ref-type="bibr" rid="B90">2005</xref>, <xref ref-type="bibr" rid="B91">2008</xref>). These phosphorylation sites are also regulated during an ischemic insult, both <italic>in vivo</italic> (using the transient middle cerebral artery occlusion—MCAO, a model of focal ischemia) and <italic>in vitro</italic> (OGD). In particular, it was found that brain ischemia induces the dephosphorylation of GABA<sub>A</sub>R β3-subunit (Ser<sup>408</sup>/Ser<sup>409</sup>) <italic>in vitro</italic> and <italic>in vivo</italic> (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>). Studies with cultured hippocampal neurons subjected to OGD confirmed that the dephosphorylation of this domain is responsible for the observed increase in receptor internalization (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>). Again, the consequent reduction in the surface expression of GABA<sub>A</sub>R was correlated with ischemia-induced cell death, since the transfection of hippocampal neuron with a phospho-mimetic mutant of GABA<sub>A</sub>R β3 subunit (SS<sup>408/409</sup>AA), which does not undergo internalization, reduced significantly the OGD-induced apoptotic neuronal death (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>).</p>
<p>The destiny of GABA<sub>A</sub>R after endocytosis depends on their interaction with HAP1 (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). Under physiologic conditions most internalized GABA<sub>A</sub>R are rapidly recycled back to the plasma membrane, by a mechanism dependent of HAP1, while the remaining pool of receptors undergoes lysosomal degradation (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). Cultured hippocampal neurons subjected to OGD showed an impairment in receptor recycling that was correlated with a decrease in the interaction of the receptor with HAP1. This protein is indeed downregulated during OGD condition by a calpain mediated mechanism. When overexpressed, HAP1 protected hippocampal neurons from OGD-induced cell death (Mele et al., <xref ref-type="bibr" rid="B116">2017</xref>).</p>
<p>The reported reduction in the number of synaptic GABA<sub>A</sub>R observed in brain ischemia may also be directly related with the ubiquitination-dependent degradation of the receptors. In particular the ubiquitination of lysine residues between amino acids 317–328 within the intracellular domain of the GABA<sub>A</sub>R γ2 subunit modulates the lysosomal targeting of the receptor. This process controls the efficacy of neuronal inhibition under basal conditions by regulating the accumulation of GABA<sub>A</sub>R at inhibitory synapses (Arancibia-Cárcamo et al., <xref ref-type="bibr" rid="B3">2009</xref>). The deficit in neuronal inhibition under conditions of OGD also involves an enhanced degradation of GABA<sub>A</sub>R due to ubiquitination of a motif located within the intracellular domain of the γ2 subunit, with a consequent deficit in the cell surface stability of the receptors (Arancibia-Cárcamo et al., <xref ref-type="bibr" rid="B3">2009</xref>).</p>
<p>Together, these studies point to postsynaptic alterations of GABAergic synapses as central players in synaptic dysfunction induced by brain ischemia. The internalization of GABA<sub>A</sub>R that accounts for the impairment in inhibitory neurotransmission may also be related with the synaptic instability of the receptor. Indeed, the gephyrin scaffold protein was found to be cleaved in cultured hippocampal neurons subjected to OGD, by a calpain-dependent mechanism. The resulting disassembly of the gephyrin lattice underneath the plasma membrane is likely to cause an inefficient synaptic anchoring of GABA<sub>A</sub>R (Costa et al., <xref ref-type="bibr" rid="B26">2016</xref>). OGD also decreases GABA<sub>A</sub>R/gephyrin interaction, as shown in experiments of surface co-immunoprecipitation of GABA<sub>A</sub>R α1 subunits and gephyrin (Mele et al., <xref ref-type="bibr" rid="B118">2014</xref>). The decrease in the interaction between GABA<sub>A</sub>R and its scaffold protein gephyrin suggests a possible alteration in the membrane dynamics of the receptor. An increased mobility of the receptors at the synapse may make them less confined within this compartment, and these receptors would become more prone to be internalized. However, further experiments are needed to better understand the alteration induced by ischemic insults on the lateral diffusion of GABA<sub>A</sub>R, and the signaling mechanisms involved, contributing to the impairment of GABAergic synapse strength. The internalization of GABA<sub>A</sub>R after an ischemic injury may explain, at least in part, the failure of receptor agonists or modulators in clinical trials for stroke (Amantea and Bagetta, <xref ref-type="bibr" rid="B2">2017</xref>).</p>
<p>Alteration of the electrochemical gradient may also contribute to the impairment of GABAergic neurotransmission in brain ischemia. Several studies reported a decrease in KCC2 expression in brain ischemia (Galeffi et al., <xref ref-type="bibr" rid="B51">2004</xref>; Papp et al., <xref ref-type="bibr" rid="B135">2008</xref>; Jaenisch et al., <xref ref-type="bibr" rid="B80">2010</xref>). Transient MCAO was found to decrease KCC2 mRNA levels, 1 day after reperfusion, and a consequent downregulation in the protein levels of the transporter was detected 7 days after reperfusion (Jaenisch et al., <xref ref-type="bibr" rid="B80">2010</xref>). An attenuated expression of KCC2 in neurons subjected to an ischemic insult may trigger GABA-evoked depolarizing responses, thereby influencing plasticity and damage induced by stroke.</p>
</sec>
<sec id="s4">
<title>Animal Models of Autism Spectrum Disorders (ASD) Are Characterized by a Downregulation of GABA<sub>A</sub>R and Alteration in Their Synaptic Distribution</title>
<p>ASD is a group of early-onset developmental disorders characterized by a variety of behavioral deficits and intellectual disability (Mattina et al., <xref ref-type="bibr" rid="B110">2009</xref>). More than 80% of ASD cases are caused by genetic alterations (Rosenberg et al., <xref ref-type="bibr" rid="B148">2009</xref>; Frazier et al., <xref ref-type="bibr" rid="B45">2014</xref>; Baio et al., <xref ref-type="bibr" rid="B4">2018</xref>). However, a huge number of genes have been identified associated to ASD, making difficult the study of the physiological pathways affected by these conditions.</p>
<p>The imbalance between neuronal excitation and inhibition within cortical circuits has been suggested as a cellular mechanism accounting for the behavioral and cognitive symptoms of ASD (Jenks and Volkers, <xref ref-type="bibr" rid="B82">1992</xref>; Ramamoorthi and Lin, <xref ref-type="bibr" rid="B143">2011</xref>; Yizhar et al., <xref ref-type="bibr" rid="B184">2011</xref>). Although the neurobiological bases of ASD have not been clearly established, several genes related to autism were shown to encode synaptic proteins. Accordingly, an aberrant synaptic activity is characteristic of ASD patients (Howell and Smith, <xref ref-type="bibr" rid="B71">2019</xref>). In particular, a dysfunction in the GABAergic system has been suggested to play an important role in the pathogenesis of ASD (Nielsen, <xref ref-type="bibr" rid="B128">1990</xref>; Dhossche et al., <xref ref-type="bibr" rid="B37">2002</xref>; Pizzarelli and Cherubini, <xref ref-type="bibr" rid="B140">2011</xref>; <xref ref-type="fig" rid="F2">Figure 2</xref>).</p>
<p>A recent study reported a decreased expression of membrane associated GABA<sub>A</sub>R-β3 subunits, as well as a downregulation of the phosphorylated form of the receptor subunit, in the sodium valproate (VPA)-induced rat model of ASD. The reduced phosphorylation levels of GABA<sub>A</sub>R-β3 subunit suggests alterations in the trafficking of the receptor, namely an increase in receptor internalization. The changes in GABAergic neurotransmission induced by prenatal exposure to VPA were also associated to impaired spatial memory, limited exploration, increased anxiety, and reduced sociability (Li et al., <xref ref-type="bibr" rid="B105">2017b</xref>).</p>
<p>Alterations in the phosphorylation of GABA<sub>A</sub>R γ2 subunits may also be relevant for the ASD phenotype as shown in studies using the Ser<sup>408/409</sup>Ala homozygous mice, in which the receptor subunit shows a low interaction with the AP2 complex which decreases internalization, similarly to the behavior of phosphorylated receptors. These animals are characterized by an increase in the activity of synaptic GABA<sub>A</sub>R, together with a reduction in the extrasynaptic inhibitory currents, and exhibit the core phenotypes of ASD (Vien et al., <xref ref-type="bibr" rid="B177">2015</xref>). The <italic>fmr1</italic> KO mice which are commonly used as a model to study the fragile X syndrome and ASD also display an increased phosphorylation of GABA<sub>A</sub>R γ2 on Ser<sup>408/409</sup> (Vien et al., <xref ref-type="bibr" rid="B177">2015</xref>), further pointing to a role for alterations in the phosphorylation state of this subunit in neuropsychiatric disorders.</p>
<p>Deficits in GABA<sub>A</sub>R surface expression were also detected in mice with a loss-of-function of <italic>PX-RICS</italic> that results in ASD-like behaviors (Nakamura et al., <xref ref-type="bibr" rid="B125">2016</xref>). These mice recapitulate the pathogenic process of ASD-like behavior characteristic of Jacobsen syndrome (JBS) patients (Mattina et al., <xref ref-type="bibr" rid="B110">2009</xref>). <italic>PX-RICS</italic><sup>−/−</sup> mice exhibit a dysfunction of the postsynaptic mechanism for GABA<sub>A</sub>R trafficking. Cell surface labeling and biotinylation assays revealed that GABA<sub>A</sub>R γ2 surface expression is significantly reduced in <italic>PX-RICS</italic><sup>−/−</sup> hippocampal neurons and in cerebellar granule neurons (CGNs). Moreover, whole-cell patch–clamp experiments detected a reduction in the amplitude of mIPSCs with no significant differences in their frequency, suggesting that the postsynaptic responsiveness to inhibitory input is impaired without alteration in the presynaptic release of the neurotransmitter. Interestingly, stimulation with a GABA<sub>A</sub>R agonist improved some autistic-like phenotypes of <italic>PX-RICS</italic><sup>−/−</sup> mice (Nakamura et al., <xref ref-type="bibr" rid="B125">2016</xref>). This suggests that a potentiation of postsynaptic GABAergic signaling could be a possible therapeutic strategy for ASD-like behavior.</p>
<p>The impairment of GABAergic neurotransmission in patients with ASD is further supported by evidence showing increased levels of Hrd1 in the middle frontal cortex of patients with ASD (Crider et al., <xref ref-type="bibr" rid="B30">2014</xref>). This E3 ligase ubiquitinates misfolded GABA<sub>A</sub>R α1 subunits before ERAD in HEK293 cells (Di et al., <xref ref-type="bibr" rid="B38">2016</xref>). Interestingly, a downregulation of GABA<sub>A</sub>R α1 subunits was also detected in the middle frontal cortex of ASD patients (Crider et al., <xref ref-type="bibr" rid="B30">2014</xref>).</p>
<p>Mutations in several proteins associated with the postsynaptic density (PSD) of excitatory synapses have been associated with neuropsychiatric disorders (Volk et al., <xref ref-type="bibr" rid="B180">2015</xref>; Li et al., <xref ref-type="bibr" rid="B102">2017a</xref>; Gandal et al., <xref ref-type="bibr" rid="B53">2018</xref>). The growing interest in the characterization of the inhibitory PSD (Tyagarajan and Fritschy, <xref ref-type="bibr" rid="B173">2014</xref>) may shed light into the complexity of the mechanisms involved in the regulation of GABAergic neurotransmission and may show novel molecular players involved in the regulation of the surface dynamics of GABA<sub>A</sub>R with a role in neuropsychiatric disorders, including ASD.</p>
</sec>
<sec id="s5">
<title>GABA<sub>A</sub>-Receptor Trafficking Involvement in Neurodegenerative Disorders</title>
<p>Alterations in GABA<sub>A</sub>R trafficking coupled to the dysregulation of the synaptic excitatory/inhibitory balance are also a common feature of several neurodegenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease (HD; <xref ref-type="fig" rid="F2">Figure 2</xref>). These alterations might induce changes in synaptic strength and ultimately lead to excitotoxicity and consequent neuronal cell death.</p>
<p>AD is a chronic and progressive neurodegenerative disease characterized by memory deficits and cognitive decline owing to synaptic and neuronal loss in the hippocampus and cerebral cortex. The abnormal deposition of amyloid-β (Aβ) in these brain regions suggests that this peptide plays an essential role in AD pathogenesis (Karran and De Strooper, <xref ref-type="bibr" rid="B88">2016</xref>). In fact, the observed deleterious effects of Aβ were shown to arise, in part, from the interaction of the peptide with NMDAR, causing excitotoxity and neuronal dysfunction (Costa et al., <xref ref-type="bibr" rid="B27">2012</xref>).</p>
<p>GABAergic signaling was also demonstrated to be profoundly altered in the AD brain (Limon et al., <xref ref-type="bibr" rid="B106">2012</xref>). Indeed, GABA currents were shown to desensitize faster and the GABA<sub>A</sub>R were found to be less sensitive to GABA after micro-transplantation of membranes from the temporal cortex of AD patients into <italic>Xenopus oocytes</italic> (Limon et al., <xref ref-type="bibr" rid="B106">2012</xref>). Aβ was also shown to weaken synaptic inhibition through downregulation of GABA<sub>A</sub>R <italic>via</italic> receptor endocytosis (Ulrich, <xref ref-type="bibr" rid="B175">2015</xref>). Accordingly, Aβ induced a decline in mIPSCs in layer V pyramidal neurons, an effect that was prevented using an inhibitor of the dynamin-mediated internalization of GABA<sub>A</sub>R (Ulrich, <xref ref-type="bibr" rid="B175">2015</xref>). This result indicates that the observed hyperexcitability characteristic of AD could be partly related with the loss of functional GABA<sub>A</sub>R observed in the AD brain (Limon et al., <xref ref-type="bibr" rid="B106">2012</xref>) and with the loss of synaptic inhibitory strength induced by Aβ (Ulrich, <xref ref-type="bibr" rid="B175">2015</xref>).</p>
<p>In the context of AD, GABA<sub>A</sub>R were also show to suffer several consistent alterations in their subunit composition (e.g., α1, α2, α5, β2, β3 and γ2), in different brain regions, namely in the hippocampus (Kwakowsky et al., <xref ref-type="bibr" rid="B99">2018</xref>). The complexity of these alterations is not compatible with simple compensatory mechanisms, but may reflect instead the reorganization of defined neuronal circuits (Kwakowsky et al., <xref ref-type="bibr" rid="B99">2018</xref>). Despite these results, the effects of Aβ on inhibitory synapses are still poorly understood as most studies have focused on the impairment of excitatory synaptic transmission. In particular, the signaling pathways by which Aβ induce GABA<sub>A</sub>R endocytosis remain to be investigated. Since Aβ enhances neuronal excitability though NMDA activation and synaptic plasticity (Parihar and Brewer, <xref ref-type="bibr" rid="B136">2010</xref>; Costa et al., <xref ref-type="bibr" rid="B27">2012</xref>; Varga et al., <xref ref-type="bibr" rid="B176">2014</xref>), this may constitute the signal to induce the internalization of GABA<sub>A</sub>R. Future studies should also address a possible direct interaction of Aβ with GABA<sub>A</sub>R or with proteins associated with the inhibitory PSD. Whether the tau pathology in AD is also somehow related with alterations in GABA<sub>A</sub>R traffic also remains to be investigated. Furthermore, the implications of the alteration in GABA<sub>A</sub>R trafficking in AD progression are still unclear. Several studies suggested that part of the symptoms associated to this disorder might be caused by the loss of the synaptic excitatory/inhibitory balance (Michels and Moss, <xref ref-type="bibr" rid="B119">2007</xref>; McDade et al., <xref ref-type="bibr" rid="B113">2009</xref>; Ulrich, <xref ref-type="bibr" rid="B175">2015</xref>).</p>
<p>Alterations in GABA<sub>A</sub>R trafficking have also been associated with PD. This long-term neurodegenerative disorder mainly affects the motor system and causes a characteristic combination of motor symptoms (e.g., hypertonia) due to progressive neurodegeneration of dopaminergic neurons (Gilbert et al., <xref ref-type="bibr" rid="B55">2006</xref>; Meder et al., <xref ref-type="bibr" rid="B115">2018</xref>). The symptomatic treatment of hypertonia can be achieved by enhancing GABAergic transmission. Indeed, the regulation of GABA<sub>A</sub>R homeostasis was reported to be disrupted in a hypertonic mouse model bearing a mutation in the <italic>hyrt</italic> gene, which codes for the trafficking protein kinesin binding 1 (Trak1). This study showed a marked reduction in the levels GABA<sub>A</sub>R in the CNS, particularly in the lower motor neurons, and, interestingly, Trak1 was found to interact with GABA<sub>A</sub>R (Gilbert et al., <xref ref-type="bibr" rid="B55">2006</xref>). Trak1 (and Trak2) shares some homology with HAP1 (Li et al., <xref ref-type="bibr" rid="B104">1995</xref>), which has been implicated in intracellular trafficking and transport of GABA<sub>A</sub>R (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>; Gilbert et al., <xref ref-type="bibr" rid="B55">2006</xref>). In contrast with the effect on the expression of GABA<sub>A</sub>R, the distribution of the GABA<sub>A</sub>R anchoring protein gephyrin was not altered in <italic>hyrt</italic> mice. Therefore, the reduction in GABA<sub>A</sub>R in <italic>hyrt</italic> mice may be due to the dysregulation of GABA<sub>A</sub>R endocytic trafficking rather than to the destabilization of the plasma membrane complex that stabilizes the receptors at the synapse (Gilbert et al., <xref ref-type="bibr" rid="B55">2006</xref>). Thus, it can be hypothesized that Trak1 may facilitate the targeting of endocytosed receptors back to the membrane or it may block their degradation. Interestingly, no significant degeneration of GABAergic neurons was observed in <italic>hyrt</italic> mice despite the reduction in the levels of GABA<sub>A</sub>R subunits in this hypertonic mouse model (Gilbert et al., <xref ref-type="bibr" rid="B55">2006</xref>), as described for AD (Ulrich, <xref ref-type="bibr" rid="B175">2015</xref>).</p>
<p>Other proteins have been associated with the reduction of GABA<sub>A</sub>R surface expression in PD. GABARAPs are a family of proteins that play a role in vesicle and receptor trafficking (Kittler et al., <xref ref-type="bibr" rid="B94">2001</xref>), and in particular they were shown to interact and regulate the intracellular trafficking of GABA<sub>A</sub>R (Wang et al., <xref ref-type="bibr" rid="B181">1999</xref>; Chen et al., <xref ref-type="bibr" rid="B22">2001</xref>; Chen and Olsen, <xref ref-type="bibr" rid="B23">2007</xref>). Furthermore, members of this protein family have been implicated in autophagy (Rowland et al., <xref ref-type="bibr" rid="B149">2006</xref>; Schwarten et al., <xref ref-type="bibr" rid="B154">2009</xref>), a mechanism involved in GABA<sub>A</sub>R clearance (Rowland et al., <xref ref-type="bibr" rid="B149">2006</xref>). A recent study showed that GABARAPs also bind the parkin-associated endothelin-like receptor (PAELR; Dutta et al., <xref ref-type="bibr" rid="B40">2018</xref>), which is localized in the core of Lewy bodies, a PD hallmark (Murakami et al., <xref ref-type="bibr" rid="B124">2004</xref>). Furthermore, PAELR interacts with the GABA<sub>A</sub>R binding site of GABARAPL2, and this protein together with Parkin and PICK1 are most likely involved in the regulation of PAELR protein levels. This occurs <italic>via</italic> autophagy, ubiquitination and proteasomal degradation (Dutta et al., <xref ref-type="bibr" rid="B40">2018</xref>), which ultimately might lead to the regulation of GABA<sub>A</sub>R trafficking. However, additional studies are required to establish a role for GABARAPs in PD.</p>
<p>HD is an autosomal dominant progressive neurodegenerative disorder caused by the mutant huntingtin (Htt), with an expanded polyglutamine (polyQ) repeat (McClory et al., <xref ref-type="bibr" rid="B111">2014</xref>). This disorder is characterized by progressive involuntary choreiform movements, emotional disturbances and cognitive decline (Pinborg et al., <xref ref-type="bibr" rid="B139">2001</xref>), associated with degeneration of GABAergic neurons (Fritschy and Brünig, <xref ref-type="bibr" rid="B47">2003</xref>).</p>
<p>An early study using emission tomography methods (PET and SPECT) showed a reduction in the abundance of benzodiazepine receptors in the striatum (but not in the cortex) of HD patients (Pinborg et al., <xref ref-type="bibr" rid="B139">2001</xref>). These binding sites are present in GABA<sub>A</sub>R containing, for example, α1, α2, α3, or α5 subunits, together with β and γ subunits, and are mainly located at the synapse where they mediate most phasic inhibition in the brain (Jacob et al., <xref ref-type="bibr" rid="B78">2008</xref>). This contrasts with the extrasynaptic GABA<sub>A</sub>R that mediate tonic inhibition, which are insensitive to benzodiazepines (Jacob et al., <xref ref-type="bibr" rid="B78">2008</xref>). The putative alterations in the expression of GABA<sub>A</sub>R in HD requires further investigation since immunohistochemistry experiments showed an increase in the abundance of the α1 and γ2 receptor subunits in the globus pallidus of patients with the disease, while the levels of gephyrin were not changed (Thompson-Vest et al., <xref ref-type="bibr" rid="B169">2003</xref>). The discrepancy between the results obtained in the analysis of benzodiazepine receptors and expression of GABA<sub>A</sub>R subunits may be due to differences in the brain regions analyzed, which was more restricted in the latter case.</p>
<p>In contrast with the evidence showing changes in the abundance of GABA<sub>A</sub>R in certain brain regions of HD patients, the alterations in receptor trafficking in the disease have been poorly investigated. As mentioned before, HAP1 interacts directly with GABA<sub>A</sub>R and regulates inhibitory synaptic transmission by modulating GABA<sub>A</sub>R recycling (Kittler et al., <xref ref-type="bibr" rid="B95">2004b</xref>). GABA<sub>A</sub>R are trafficked to synapses by the kinesin family motor protein 5 (KIF5), which mediates the insertion of GABA<sub>A</sub>R into the plasma membrane, and HAP1, the adaptor that links the motor protein to the receptors. Accordingly, HAP1-KIF5 dependent GABA<sub>A</sub>R trafficking was reported as a fundamental mechanism controlling the strength of synaptic inhibition in the brain (Twelvetrees et al., <xref ref-type="bibr" rid="B172">2010</xref>). Mutant huntingtin containing a polyQ expansion disrupts the HAP1-KIF5 GABA<sub>A</sub>R trafficking and synaptic delivery (Twelvetrees et al., <xref ref-type="bibr" rid="B172">2010</xref>). Thus, the disruption of this complex by mutant huntingtin may lead to altered synaptic inhibition and increased neuronal excitability in HD (Twelvetrees et al., <xref ref-type="bibr" rid="B172">2010</xref>).</p>
<p>The disruption of GABA<sub>A</sub>R trafficking and synaptic inhibition was also observed in a mouse model of HD (Yuen et al., <xref ref-type="bibr" rid="B185">2012</xref>). In the latter study, GABA<sub>A</sub>R-mediated inhibitory transmission was found to be disrupted in the HD at the symptomatic stage, a consequence of a diminished surface GABA<sub>A</sub>R expression, which may underlie the impaired GABAergic transmission (Yuen et al., <xref ref-type="bibr" rid="B185">2012</xref>). Furthermore, the KIF5-mediated microtubule-based transport of GABA<sub>A</sub>R was confirmed to be impaired in HD, which may underlie the disruption of GABA<sub>A</sub>R trafficking to the synaptic membrane. Therefore, the interference in the effect of polyQ-Htt on the HAP1/KIF5-mediated trafficking of GABA<sub>A</sub>R to synapses may constitute a therapeutic approach for HD, by restoring synaptic function (Yuen et al., <xref ref-type="bibr" rid="B185">2012</xref>).</p>
<p>The chronic neuroinflammation observed in these neurodegenerative disorders induces the upregulation of tumor necrosis factor-α (TNF-α), which might play a role in the observed synaptic excitatory/inhibitory unbalance (Frankola et al., <xref ref-type="bibr" rid="B44">2011</xref>). TNF-α was already described as an important mediator of homeostatic synaptic plasticity (Stellwagen and Malenka, <xref ref-type="bibr" rid="B163">2006</xref>), and, interestingly, it was shown to modulate GABA<sub>A</sub>R trafficking, thereby downregulating the inhibitory neurotransmission. Indeed, TNF-α enhances the association of protein phosphatase 1 (PP1) with GABA<sub>A</sub>R β3 subunits and dephosphorylates the amino acid residue of the β3 subunit responsible for the regulation of the phospho-dependent interactions with the endocytic machinery (Pribiag and Stellwagen, <xref ref-type="bibr" rid="B141">2013</xref>).</p>
</sec>
<sec id="s6">
<title>Final Remarks</title>
<p>Aberrant excitability is a common feature of numerous disorders of the CNS. Dysfunction of GABAergic synapses and in particular alterations of postsynaptic GABA<sub>A</sub>R trafficking have been reported as a key mechanism that contributes to the unbalance between excitation an inhibition, which ultimately will lead to neuronal hyperexcitability. Interestingly, similar alterations in the mechanism coupled to an increased internalization of GABA<sub>A</sub>R result in distinct outcomes/symptoms associated to different pathologies of the CNS. Depending on the circuits, the brain region and the developmental stage in which the postsynaptic alteration of GABAergic system is initiated, different structural and molecular modifications of the involved neurons may occur, triggering distinct pathologic responses. However, the disruption of the GABAergic neurotransmission characteristic of various illnesses may partly account for some common symptoms. For example, patients with cerebral ischemia, as well as certain cases of ASD or HD (Gambardella et al., <xref ref-type="bibr" rid="B52">2001</xref>), may present seizures that are a hallmark of epilepsy. The reviewed studies indicate that the mechanisms involved in the control of plasma membrane and synaptic expression of GABA<sub>A</sub>R are key players in the modulation of neuronal excitability. However, considering the recent findings showing that the nanoscale redistribution of the scaffold protein gephyrin is a key event in the potentiation of inhibitory synapses, additional studies are required to evaluate the alterations in GABA<sub>A</sub>R and gephyrin nanoscale redistribution induced by hyperexcitability in pathological conditions. The outcome of this type of studies may contribute to the identification of novel therapeutic targets for various brain disorders characterized by an impaired regulation of the excitation/inhibition balance.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>MM, RC and CD wrote the manuscript.</p>
</sec>
<sec id="s8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> This work was financed by the European Regional Development Fund (ERDF), through the Centro 2020 Regional Operational Programme under project CENTRO-01-0145-FEDER-000008:BrainHealth 2020, and through the COMPETE 2020—Operational Programme for Competitiveness and Internationalisation and Portuguese national funds <italic>via</italic> FCT—Fundação para a Ciência e a Tecnologia, I.P., under projects POCI-01-0145-FEDER-007440 and CENTRO-01-0145-FEDER-030659. FCT also supported the following individual grants: SFRH/BPD/115546/2016 (MM) and SFRH/BPD/84593/2012 (RC).</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ali Rodriguez</surname><given-names>R.</given-names></name><name><surname>Joya</surname><given-names>C.</given-names></name><name><surname>Hines</surname><given-names>R. M.</given-names></name></person-group> (<year>2018</year>). <article-title>Common ribs of inhibitory synaptic dysfunction in the umbrella of neurodevelopmental disorders</article-title>. <source/>Front. Mol. Neurosci.
<volume>11</volume>:<fpage>132</fpage>. <pub-id pub-id-type="doi">10.3389/fnmol.2018.00132</pub-id><pub-id pub-id-type="pmid">29740280</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amantea</surname><given-names>D.</given-names></name><name><surname>Bagetta</surname><given-names>G.</given-names></name></person-group> (<year>2017</year>). <article-title>Excitatory and inhibitory amino acid neurotransmitters in stroke: from neurotoxicity to ischemic tolerance</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>35</volume>, <fpage>111</fpage>–<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2017.07.014</pub-id><pub-id pub-id-type="pmid">28826602</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arancibia-Cárcamo</surname><given-names>I. L.</given-names></name><name><surname>Yuen</surname><given-names>E. Y.</given-names></name><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Saliba</surname><given-names>R. S.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Ubiquitin-dependent lysosomal targeting of GABA<sub>A</sub> receptors regulates neuronal inhibition</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>106</volume>, <fpage>17552</fpage>–<lpage>17557</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0905502106</pub-id><pub-id pub-id-type="pmid">19815531</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baio</surname><given-names>J.</given-names></name><name><surname>Wiggins</surname><given-names>L.</given-names></name><name><surname>Christensen</surname><given-names>D. L.</given-names></name><name><surname>Maenner</surname><given-names>M. J.</given-names></name><name><surname>Daniels</surname><given-names>J.</given-names></name><name><surname>Warren</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, united states, 2014</article-title>. <source/>MMWR Surveill. Summ.
<volume>67</volume>, <fpage>1</fpage>–<lpage>23</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.ss6706a1</pub-id><pub-id pub-id-type="pmid">29701730</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>S.</given-names></name><name><surname>Teissére</surname><given-names>J. A.</given-names></name><name><surname>Raju</surname><given-names>D. V.</given-names></name><name><surname>Hall</surname><given-names>R. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Hetero-oligomerization between GABA<sub>A</sub> and GABA<sub>B</sub> receptors regulates GABA<sub>B</sub> receptor trafficking</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>18840</fpage>–<lpage>18850</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M313470200</pub-id><pub-id pub-id-type="pmid">14966130</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Lévi</surname><given-names>S.</given-names></name><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Inoue</surname><given-names>T.</given-names></name><name><surname>Launey</surname><given-names>T.</given-names></name><name><surname>Racine</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Activity-dependent tuning of inhibitory neurotransmission based on GABA<sub>A</sub>R diffusion dynamics</article-title>. <source/>Neuron
<volume>62</volume>, <fpage>670</fpage>–<lpage>682</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.04.023</pub-id><pub-id pub-id-type="pmid">19524526</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bassani</surname><given-names>S.</given-names></name><name><surname>Cwetsch</surname><given-names>A. W.</given-names></name><name><surname>Gerosa</surname><given-names>L.</given-names></name><name><surname>Serratto</surname><given-names>G. M.</given-names></name><name><surname>Folci</surname><given-names>A.</given-names></name><name><surname>Hall</surname><given-names>I. F.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>The female epilepsy protein PCDH19 is a new GABA<sub>A</sub>R-binding partner that regulates GABAergic transmission as well as migration and morphological maturation of hippocampal neurons</article-title>. <source/>Hum. Mol. Genet.
<volume>27</volume>, <fpage>1027</fpage>–<lpage>1038</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddy019</pub-id><pub-id pub-id-type="pmid">29360992</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beck</surname><given-names>M.</given-names></name><name><surname>Brickley</surname><given-names>K.</given-names></name><name><surname>Wilkinson</surname><given-names>H. L.</given-names></name><name><surname>Sharma</surname><given-names>S.</given-names></name><name><surname>Smith</surname><given-names>M.</given-names></name><name><surname>Chazot</surname><given-names>P. L.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Identification, molecular cloning, and characterization of a novel GABA<sub>A</sub> receptor-associated protein, GRIF-1</article-title>. <source/>J. Biol. Chem.
<volume>277</volume>, <fpage>30079</fpage>–<lpage>30090</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M200438200</pub-id><pub-id pub-id-type="pmid">12034717</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bedford</surname><given-names>F. K.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Muller</surname><given-names>E.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Uren</surname><given-names>J. M.</given-names></name><name><surname>Merlo</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>GABA<sub>A</sub> receptor cell surface number and subunit stability are regulated by the ubiquitin-like protein Plic-1</article-title>. <source/>Nat. Neurosci.
<volume>4</volume>, <fpage>908</fpage>–<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1038/nn0901-908</pub-id><pub-id pub-id-type="pmid">11528422</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ben-Ari</surname><given-names>Y.</given-names></name></person-group> (<year>2002</year>). <article-title>Excitatory actions of GABA during development: the nature of the nurture</article-title>. <source/>Nat. Rev. Neurosci.
<volume>3</volume>, <fpage>728</fpage>–<lpage>739</lpage>. <pub-id pub-id-type="doi">10.1038/nrn920</pub-id><pub-id pub-id-type="pmid">12209121</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besag</surname><given-names>F. M.</given-names></name></person-group> (<year>2004</year>). <article-title>Behavioral aspects of pediatric epilepsy syndromes</article-title>. <source/>Epilepsy Behav.
<volume>5</volume>, <fpage>S3</fpage>–<lpage>S13</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2003.11.002</pub-id><pub-id pub-id-type="pmid">14725841</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blaesse</surname><given-names>P.</given-names></name><name><surname>Airaksinen</surname><given-names>M. S.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Kaila</surname><given-names>K.</given-names></name></person-group> (<year>2009</year>). <article-title>Cation-chloride cotransporters and neuronal function</article-title>. <source/>Neuron
<volume>61</volume>, <fpage>820</fpage>–<lpage>838</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.03.003</pub-id><pub-id pub-id-type="pmid">19323993</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>R. E.</given-names></name><name><surname>Sombati</surname><given-names>S.</given-names></name><name><surname>Lawrence</surname><given-names>D. C.</given-names></name><name><surname>McCay</surname><given-names>B. D.</given-names></name><name><surname>DeLorenzo</surname><given-names>R. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Epileptogenesis causes acute and chronic increases in GABA<sub>A</sub> receptor endocytosis that contributes to the induction and maintenance of seizures in the hippocampal culture model of acquired epilepsy</article-title>. <source/>J. Pharmacol. Exp. Ther.
<volume>310</volume>, <fpage>871</fpage>–<lpage>880</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.068478</pub-id><pub-id pub-id-type="pmid">15084648</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bogdanov</surname><given-names>Y.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Armstrong-Gold</surname><given-names>C.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name><name><surname>Lindstrom</surname><given-names>J.</given-names></name><name><surname>Pangalos</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Synaptic GABA<sub>A</sub> receptors are directly recruited from their extrasynaptic counterparts</article-title>. <source/>EMBO J.
<volume>25</volume>, <fpage>4381</fpage>–<lpage>4389</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7601309</pub-id><pub-id pub-id-type="pmid">16946701</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Jovanovic</surname><given-names>J. N.</given-names></name><name><surname>Colledge</surname><given-names>M.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Brandon</surname><given-names>J. M.</given-names></name><name><surname>Scott</surname><given-names>J. D.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>A-kinase anchoring protein 79/150 facilitates the phosphorylation of GABA<sub>A</sub> receptors by cAMP-dependent protein kinase via selective interaction with receptor β subunits</article-title>. <source/>Mol. Cell. Neurosci.
<volume>22</volume>, <fpage>87</fpage>–<lpage>97</lpage>. <pub-id pub-id-type="doi">10.1016/s1044-7431(02)00017-9</pub-id><pub-id pub-id-type="pmid">12595241</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brandon</surname><given-names>N.</given-names></name><name><surname>Jovanovic</surname><given-names>J.</given-names></name><name><surname>Moss</surname><given-names>S.</given-names></name></person-group> (<year>2002</year>). <article-title>Multiple roles of protein kinases in the modulation of γ-aminobutyric acid<sub>A</sub> receptor function and cell surface expression</article-title>. <source/>Pharmacol. Ther.
<volume>94</volume>, <fpage>113</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/s0163-7258(02)00175-4</pub-id><pub-id pub-id-type="pmid">12191597</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brünig</surname><given-names>I.</given-names></name><name><surname>Scotti</surname><given-names>E.</given-names></name><name><surname>Sidler</surname><given-names>C.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name></person-group> (<year>2002</year>). <article-title>Intact sorting, targeting, and clustering of γ-aminobutyric acid A receptor subtypes in hippocampal neurons <italic>in vitro</italic></article-title>. <source/>J. Comp. Neurol.
<volume>443</volume>, <fpage>43</fpage>–<lpage>55</lpage>. <pub-id pub-id-type="doi">10.1002/cne.10102</pub-id><pub-id pub-id-type="pmid">11793346</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chao</surname><given-names>H. T.</given-names></name><name><surname>Chen</surname><given-names>H.</given-names></name><name><surname>Samaco</surname><given-names>R. C.</given-names></name><name><surname>Xue</surname><given-names>M.</given-names></name><name><surname>Chahrour</surname><given-names>M.</given-names></name><name><surname>Yoo</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes</article-title>. <source/>Nature
<volume>468</volume>, <fpage>263</fpage>–<lpage>269</lpage>. <pub-id pub-id-type="doi">10.1038/nature09582</pub-id><pub-id pub-id-type="pmid">21068835</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charych</surname><given-names>E. I.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Li</surname><given-names>R.</given-names></name><name><surname>Serwanski</surname><given-names>D. R.</given-names></name><name><surname>Miralles</surname><given-names>C. P.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2004a</year>). <article-title>A four PDZ domain-containing splice variant form of GRIP1 is localized in GABAergic and glutamatergic synapses in the brain</article-title>. <source/>J. Biol. Chem.
<volume>279</volume>, <fpage>38978</fpage>–<lpage>38990</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m405786200</pub-id><pub-id pub-id-type="pmid">15226318</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charych</surname><given-names>E. I.</given-names></name><name><surname>Yu</surname><given-names>W.</given-names></name><name><surname>Miralles</surname><given-names>C. P.</given-names></name><name><surname>Serwanski</surname><given-names>D. R.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Rubio</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2004b</year>). <article-title>The brefeldin A-inhibited GDP/GTP exchange factor 2, a protein involved in vesicular trafficking, interacts with the β subunits of the GABA receptors</article-title>. <source/>J. Neurochem.
<volume>90</volume>, <fpage>173</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02481.x</pub-id><pub-id pub-id-type="pmid">15198677</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z. W.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2007</year>). <article-title>GABA<sub>A</sub> receptor associated proteins: a key factor regulating GABA<sub>A</sub> receptor function</article-title>. <source/>J. Neurochem.
<volume>100</volume>, <fpage>279</fpage>–<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2006.04206.x</pub-id><pub-id pub-id-type="pmid">17083446</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q. X.</given-names></name><name><surname>Wong</surname><given-names>R. K.</given-names></name></person-group> (<year>1995</year>). <article-title>Suppression of GABA<sub>A</sub> receptor responses by NMDA application in hippocampal neurones acutely isolated from the adult guinea-pig</article-title>. <source/>J. Physiol.
<volume>482</volume>, <fpage>353</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.1995.sp020522</pub-id><pub-id pub-id-type="pmid">7714826</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Z.</given-names></name><name><surname>Xin</surname><given-names>Y. R.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Jiang</surname><given-names>J. X.</given-names></name></person-group> (<year>2001</year>). <article-title>Cloning a novel mouse Gabarapl2 cDNA and its characterization</article-title>. <source/>Acta Pharmacol. Sin.
<volume>22</volume>, <fpage>751</fpage>–<lpage>755</lpage>. <pub-id pub-id-type="pmid">11749851</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>Y. J.</given-names></name><name><surname>Kim</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>W. J.</given-names></name><name><surname>Chung</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>Y. H.</given-names></name><name><surname>Cho</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Trafficking patterns of NMDA and GABA<sub>A</sub> receptors in a Mg<sup>2+</sup>-free cultured hippocampal neuron model of status epilepticus</article-title>. <source/>Epilepsy Res.
<volume>136</volume>, <fpage>143</fpage>–<lpage>148</lpage>. <pub-id pub-id-type="doi">10.1016/j.eplepsyres.2017.08.003</pub-id><pub-id pub-id-type="pmid">28858777</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cossette</surname><given-names>P.</given-names></name><name><surname>Liu</surname><given-names>L.</given-names></name><name><surname>Brisebois</surname><given-names>K.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Lortie</surname><given-names>A.</given-names></name><name><surname>Vanasse</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy</article-title>. <source/>Nat. Genet.
<volume>31</volume>, <fpage>184</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1038/ng885</pub-id><pub-id pub-id-type="pmid">11992121</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>R. O.</given-names></name><name><surname>Lacor</surname><given-names>P. N.</given-names></name><name><surname>Ferreira</surname><given-names>I. L.</given-names></name><name><surname>Resende</surname><given-names>R.</given-names></name><name><surname>Auberson</surname><given-names>Y. P.</given-names></name><name><surname>Klein</surname><given-names>W. L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers</article-title>. <source/>Aging Cell
<volume>11</volume>, <fpage>823</fpage>–<lpage>833</lpage>. <pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00848.x</pub-id><pub-id pub-id-type="pmid">22708890</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>J. T.</given-names></name><name><surname>Mele</surname><given-names>M.</given-names></name><name><surname>Baptista</surname><given-names>M. S.</given-names></name><name><surname>Gomes</surname><given-names>J. R.</given-names></name><name><surname>Ruscher</surname><given-names>K.</given-names></name><name><surname>Nobre</surname><given-names>R. J.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Gephyrin cleavage in <italic>in vitro</italic> brain ischemia decreases GABA<sub>A</sub> receptor clustering and contributes to neuronal death</article-title>. <source/>Mol. Neurobiol.
<volume>53</volume>, <fpage>3513</fpage>–<lpage>3527</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9283-2</pub-id><pub-id pub-id-type="pmid">26093381</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coull</surname><given-names>J. A.</given-names></name><name><surname>Boudreau</surname><given-names>D.</given-names></name><name><surname>Bachand</surname><given-names>K.</given-names></name><name><surname>Prescott</surname><given-names>S. A.</given-names></name><name><surname>Nault</surname><given-names>F.</given-names></name><name><surname>Sik</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2003</year>). <article-title>Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain</article-title>. <source/>Nature
<volume>424</volume>, <fpage>938</fpage>–<lpage>942</lpage>. <pub-id pub-id-type="doi">10.1038/nature01868</pub-id><pub-id pub-id-type="pmid">12931188</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crestani</surname><given-names>F.</given-names></name><name><surname>Keist</surname><given-names>R.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Vogt</surname><given-names>K.</given-names></name><name><surname>Prut</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Trace fear conditioning involves hippocampal α5 GABA<sub>A</sub> receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>99</volume>, <fpage>8980</fpage>–<lpage>8985</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.142288699</pub-id><pub-id pub-id-type="pmid">12084936</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crider</surname><given-names>A.</given-names></name><name><surname>Pandya</surname><given-names>C. D.</given-names></name><name><surname>Peter</surname><given-names>D.</given-names></name><name><surname>Ahmed</surname><given-names>A. O.</given-names></name><name><surname>Pillai</surname><given-names>A.</given-names></name></person-group> (<year>2014</year>). <article-title>Ubiquitin-proteasome dependent degradation of GABA<sub>A</sub> α1 in autism spectrum disorder</article-title>. <source/>Mol. Autism
<volume>5</volume>:<fpage>45</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-5-45</pub-id><pub-id pub-id-type="pmid">25392730</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Curia</surname><given-names>G.</given-names></name><name><surname>Longo</surname><given-names>D.</given-names></name><name><surname>Biagini</surname><given-names>G.</given-names></name><name><surname>Jones</surname><given-names>R. S.</given-names></name><name><surname>Avoli</surname><given-names>M.</given-names></name></person-group> (<year>2008</year>). <article-title>The pilocarpine model of temporal lobe epilepsy</article-title>. <source/>J. Neurosci. Methods
<volume>172</volume>, <fpage>143</fpage>–<lpage>157</lpage>. <pub-id pub-id-type="doi">10.1016/j.jneumeth.2008.04.019</pub-id><pub-id pub-id-type="pmid">18550176</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czuczwar</surname><given-names>S. J.</given-names></name><name><surname>Patsalos</surname><given-names>P. N.</given-names></name></person-group> (<year>2001</year>). <article-title>The new generation of GABA enhancers. Potential in the treatment of epilepsy</article-title>. <source/>CNS Drugs
<volume>15</volume>, <fpage>339</fpage>–<lpage>350</lpage>. <pub-id pub-id-type="doi">10.2165/00023210-200115050-00001</pub-id><pub-id pub-id-type="pmid">11475940</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Koninck</surname><given-names>Y.</given-names></name></person-group> (<year>2007</year>). <article-title>Altered chloride homeostasis in neurological disorders: a new target</article-title>. <source/>Curr. Opin. Pharmacol.
<volume>7</volume>, <fpage>93</fpage>–<lpage>99</lpage>. <pub-id pub-id-type="doi">10.1016/j.coph.2006.11.005</pub-id><pub-id pub-id-type="pmid">17182282</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>de Luca</surname><given-names>E.</given-names></name><name><surname>Ravasenga</surname><given-names>T.</given-names></name><name><surname>Petrini</surname><given-names>E. M.</given-names></name><name><surname>Polenghi</surname><given-names>A.</given-names></name><name><surname>Nieus</surname><given-names>T.</given-names></name><name><surname>Guazzi</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Inter-synaptic lateral diffusion of GABA<sub>A</sub> receptors shapes inhibitory synaptic currents</article-title>. <source/>Neuron
<volume>95</volume>, <fpage>63.e5</fpage>–<lpage>69.e5</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2017.06.022</pub-id><pub-id pub-id-type="pmid">28683270</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dejanovic</surname><given-names>B.</given-names></name><name><surname>Djémié</surname><given-names>T.</given-names></name><name><surname>Grünewald</surname><given-names>N.</given-names></name><name><surname>Suls</surname><given-names>A.</given-names></name><name><surname>Kress</surname><given-names>V.</given-names></name><name><surname>Hetsch</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Simultaneous impairment of neuronal and metabolic function of mutated gephyrin in a patient with epileptic encephalopathy</article-title>. <source/>EMBO Mol. Med.
<volume>9</volume>:<fpage>1764</fpage>. <pub-id pub-id-type="doi">10.15252/emmm.201708525</pub-id><pub-id pub-id-type="pmid">29196314</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Deykin</surname><given-names>E. Y.</given-names></name><name><surname>MacMahon</surname><given-names>B.</given-names></name></person-group> (<year>1979</year>). <article-title>The incidence of seizures among children with autistic symptoms</article-title>. <source/>Am. J. Psychiatry
<volume>136</volume>, <fpage>1310</fpage>–<lpage>1312</lpage>. <pub-id pub-id-type="doi">10.1176/ajp.136.10.1310</pub-id><pub-id pub-id-type="pmid">484727</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dhossche</surname><given-names>D.</given-names></name><name><surname>Applegate</surname><given-names>H.</given-names></name><name><surname>Abraham</surname><given-names>A.</given-names></name><name><surname>Maertens</surname><given-names>P.</given-names></name><name><surname>Bland</surname><given-names>L.</given-names></name><name><surname>Bencsath</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Elevated plasma γ-aminobutyric acid (GABA) levels in autistic youngsters: stimulus for a GABA hypothesis of autism</article-title>. <source/>Med. Sci. Monit.
<volume>8</volume>, <fpage>PR1</fpage>–<lpage>6</lpage>. <pub-id pub-id-type="pmid">12165753</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di</surname><given-names>X. J.</given-names></name><name><surname>Wang</surname><given-names>Y. J.</given-names></name><name><surname>Han</surname><given-names>D. Y.</given-names></name><name><surname>Fu</surname><given-names>Y. L.</given-names></name><name><surname>Duerfeldt</surname><given-names>A. S.</given-names></name><name><surname>Blagg</surname><given-names>B. S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Grp94 protein delivers γ-aminobutyric acid type A (GABA<sub>A</sub>) receptors to Hrd1 protein-mediated endoplasmic reticulum-associated degradation</article-title>. <source/>J. Biol. Chem.
<volume>291</volume>, <fpage>9526</fpage>–<lpage>9539</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M115.705004</pub-id><pub-id pub-id-type="pmid">26945068</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Zhang</surname><given-names>P.</given-names></name><name><surname>Song</surname><given-names>I.</given-names></name><name><surname>Petralia</surname><given-names>R. S.</given-names></name><name><surname>Liao</surname><given-names>D.</given-names></name><name><surname>Huganir</surname><given-names>R. L.</given-names></name></person-group> (<year>1999</year>). <article-title>Characterization of the glutamate receptor-interacting proteins GRIP1 and GRIP2</article-title>. <source/>J. Neurosci.
<volume>19</volume>, <fpage>6930</fpage>–<lpage>6941</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.19-16-06930.1999</pub-id><pub-id pub-id-type="pmid">10436050</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dutta</surname><given-names>P.</given-names></name><name><surname>Dargahi</surname><given-names>L.</given-names></name><name><surname>O’Connell</surname><given-names>K. E.</given-names></name><name><surname>Bolia</surname><given-names>A.</given-names></name><name><surname>Ozkan</surname><given-names>B.</given-names></name><name><surname>Sailer</surname><given-names>A. W.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>A novel modelling mechanism of PAEL receptor and GABARAPL2 interaction involved in Parkinson’s disease</article-title>. <source/>Neurosci. Lett.
<volume>673</volume>, <fpage>12</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1016/j.neulet.2018.02.055</pub-id><pub-id pub-id-type="pmid">29496607</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eckel</surname><given-names>R.</given-names></name><name><surname>Szulc</surname><given-names>B.</given-names></name><name><surname>Walker</surname><given-names>M. C.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2015</year>). <article-title>Activation of calcineurin underlies altered trafficking of α2 subunit containing GABA<sub>A</sub> receptors during prolonged epileptiform activity</article-title>. <source/>Neuropharmacology
<volume>88</volume>, <fpage>82</fpage>–<lpage>90</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.09.014</pub-id><pub-id pub-id-type="pmid">25245802</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El-Hassar</surname><given-names>L.</given-names></name><name><surname>Esclapez</surname><given-names>M.</given-names></name><name><surname>Bernard</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Hyperexcitability of the CA1 hippocampal region during epileptogenesis</article-title>. <source/>Epilepsia
<volume>48</volume>, <fpage>131</fpage>–<lpage>139</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.01301.x</pub-id><pub-id pub-id-type="pmid">17910593</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>M.</given-names></name><name><surname>Shen</surname><given-names>L.</given-names></name><name><surname>Yin</surname><given-names>H.</given-names></name><name><surname>Pan</surname><given-names>Y. M.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Chen</surname><given-names>D.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Downregulation of gephyrin in temporal lobe epilepsy neurons in humans and a rat model</article-title>. <source/>Synapse
<volume>65</volume>, <fpage>1006</fpage>–<lpage>1014</lpage>. <pub-id pub-id-type="doi">10.1002/syn.20928</pub-id><pub-id pub-id-type="pmid">21404332</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frankola</surname><given-names>K. A.</given-names></name><name><surname>Greig</surname><given-names>N. H.</given-names></name><name><surname>Luo</surname><given-names>W.</given-names></name><name><surname>Tweedie</surname><given-names>D.</given-names></name></person-group> (<year>2011</year>). <article-title>Targeting TNF-α to elucidate and ameliorate neuroinflammation in neurodegenerative diseases</article-title>. <source/>CNS Neurol. Disord. Drug Targets
<volume>10</volume>, <fpage>391</fpage>–<lpage>403</lpage>. <pub-id pub-id-type="doi">10.2174/187152711794653751</pub-id><pub-id pub-id-type="pmid">21288189</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frazier</surname><given-names>T. W.</given-names></name><name><surname>Thompson</surname><given-names>L.</given-names></name><name><surname>Youngstrom</surname><given-names>E. A.</given-names></name><name><surname>Law</surname><given-names>P.</given-names></name><name><surname>Hardan</surname><given-names>A. Y.</given-names></name><name><surname>Eng</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A twin study of heritable and shared environmental contributions to autism</article-title>. <source/>J. Autism Dev. Disord.
<volume>44</volume>, <fpage>2013</fpage>–<lpage>2025</lpage>. <pub-id pub-id-type="doi">10.1007/s10803-014-2081-2</pub-id><pub-id pub-id-type="pmid">24604525</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>J. A.</given-names></name></person-group> (<year>2007</year>). <article-title>Refractory epilepsy: clinical overview</article-title>. <source/>Epilepsia
<volume>48</volume>, <fpage>3</fpage>–<lpage>7</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2007.00992.x</pub-id><pub-id pub-id-type="pmid">17316406</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Brünig</surname><given-names>I.</given-names></name></person-group> (<year>2003</year>). <article-title>Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications</article-title>. <source/>Pharmacol. Ther.
<volume>98</volume>, <fpage>299</fpage>–<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1016/s0163-7258(03)00037-8</pub-id><pub-id pub-id-type="pmid">12782242</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Harvey</surname><given-names>R. J.</given-names></name><name><surname>Schwarz</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>Gephyrin: where do we stand, where do we go?</article-title>
<source/>Trends Neurosci.
<volume>31</volume>, <fpage>257</fpage>–<lpage>264</lpage>. <pub-id pub-id-type="doi">10.1016/j.tins.2008.02.006</pub-id><pub-id pub-id-type="pmid">18403029</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Mohler</surname><given-names>H.</given-names></name></person-group> (<year>1995</year>). <article-title>GABA<sub>A</sub>-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunits</article-title>. <source/>J. Comp. Neurol.
<volume>359</volume>, <fpage>154</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1002/cne.903590111</pub-id><pub-id pub-id-type="pmid">8557845</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galanopoulou</surname><given-names>A. S.</given-names></name><name><surname>Bojko</surname><given-names>A.</given-names></name><name><surname>Lado</surname><given-names>F.</given-names></name><name><surname>Moshé</surname><given-names>S. L.</given-names></name></person-group> (<year>2000</year>). <article-title>The spectrum of neuropsychiatric abnormalities associated with electrical status epilepticus in sleep</article-title>. <source/>Brain Dev.
<volume>22</volume>, <fpage>279</fpage>–<lpage>295</lpage>. <pub-id pub-id-type="doi">10.1016/s0387-7604(00)00127-3</pub-id><pub-id pub-id-type="pmid">10891635</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Galeffi</surname><given-names>F.</given-names></name><name><surname>Sah</surname><given-names>R.</given-names></name><name><surname>Pond</surname><given-names>B. B.</given-names></name><name><surname>George</surname><given-names>A.</given-names></name><name><surname>Schwartz-Bloom</surname><given-names>R. D.</given-names></name></person-group> (<year>2004</year>). <article-title>Changes in intracellular chloride after oxygen-glucose deprivation of the adult hippocampal slice: effect of diazepam</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>4478</fpage>–<lpage>4488</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0755-04.2004</pub-id><pub-id pub-id-type="pmid">15128862</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gambardella</surname><given-names>A.</given-names></name><name><surname>Muglia</surname><given-names>M.</given-names></name><name><surname>Labate</surname><given-names>A.</given-names></name><name><surname>Magariello</surname><given-names>A.</given-names></name><name><surname>Gabriele</surname><given-names>A. L.</given-names></name><name><surname>Mazzei</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Juvenile Huntington’s disease presenting as progressive myoclonic epilepsy</article-title>. <source/>Neurology
<volume>57</volume>, <fpage>708</fpage>–<lpage>711</lpage>. <pub-id pub-id-type="doi">10.1212/wnl.57.4.708</pub-id><pub-id pub-id-type="pmid">11524486</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gandal</surname><given-names>M. J.</given-names></name><name><surname>Haney</surname><given-names>J. R.</given-names></name><name><surname>Parikshak</surname><given-names>N. N.</given-names></name><name><surname>Leppa</surname><given-names>V.</given-names></name><name><surname>Ramaswami</surname><given-names>G.</given-names></name><name><surname>Hartl</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2018</year>). <article-title>Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap</article-title>. <source/>Science
<volume>359</volume>, <fpage>693</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1126/science.aad6469</pub-id><pub-id pub-id-type="pmid">29439242</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gataullina</surname><given-names>S.</given-names></name><name><surname>Bienvenu</surname><given-names>T.</given-names></name><name><surname>Nabbout</surname><given-names>R.</given-names></name><name><surname>Huberfeld</surname><given-names>G.</given-names></name><name><surname>Dulac</surname><given-names>O.</given-names></name></person-group> (<year>2019</year>). <article-title>Gene mutations in paediatric epilepsies cause NMDA-pathy and phasic and tonic GABA-pathy</article-title>. <source/>Dev. Med. Child Neurol. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1111/dmcn.14152</pub-id><pub-id pub-id-type="pmid">30680721</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilbert</surname><given-names>S. L.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Forster</surname><given-names>M. L.</given-names></name><name><surname>Anderson</surname><given-names>J. R.</given-names></name><name><surname>Iwase</surname><given-names>T.</given-names></name><name><surname>Soliven</surname><given-names>B.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Trak1 mutation disrupts GABA<sub>A</sub> receptor homeostasis in hypertonic mice</article-title>. <source/>Nat. Genet.
<volume>38</volume>, <fpage>245</fpage>–<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1038/ng1715</pub-id><pub-id pub-id-type="pmid">16380713</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giovanardi Rossi</surname><given-names>P.</given-names></name><name><surname>Posar</surname><given-names>A.</given-names></name><name><surname>Parmeggiani</surname><given-names>A.</given-names></name></person-group> (<year>2000</year>). <article-title>Epilepsy in adolescents and young adults with autistic disorder</article-title>. <source/>Brain Dev.
<volume>22</volume>, <fpage>102</fpage>–<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1016/s0387-7604(99)00124-2</pub-id><pub-id pub-id-type="pmid">10722961</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glykys</surname><given-names>J.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>2006</year>). <article-title>Hippocampal network hyperactivity after selective reduction of tonic inhibition in GABA<sub>A</sub> receptor α5 subunit-deficient mice</article-title>. <source/>J. Neurophysiol.
<volume>95</volume>, <fpage>2796</fpage>–<lpage>2807</lpage>. <pub-id pub-id-type="doi">10.1152/jn.01122.2005</pub-id><pub-id pub-id-type="pmid">16452257</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glykys</surname><given-names>J.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>2007</year>). <article-title>The main source of ambient GABA responsible for tonic inhibition in the mouse hippocampus</article-title>. <source/>J. Physiol.
<volume>582</volume>, <fpage>1163</fpage>–<lpage>1178</lpage>. <pub-id pub-id-type="doi">10.1113/jphysiol.2007.134460</pub-id><pub-id pub-id-type="pmid">17525114</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldberg</surname><given-names>E. M.</given-names></name><name><surname>Coulter</surname><given-names>D. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction</article-title>. <source/>Nat. Rev. Neurosci.
<volume>14</volume>, <fpage>337</fpage>–<lpage>349</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3482</pub-id><pub-id pub-id-type="pmid">23595016</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>González</surname><given-names>M. I.</given-names></name><name><surname>Cruz Del Angel</surname><given-names>Y.</given-names></name><name><surname>Brooks-Kayal</surname><given-names>A.</given-names></name></person-group> (<year>2013</year>). <article-title>Down-regulation of gephyrin and GABA<sub>A</sub> receptor subunits during epileptogenesis in the CA1 region of hippocampus</article-title>. <source/>Epilepsia
<volume>54</volume>, <fpage>616</fpage>–<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12063</pub-id><pub-id pub-id-type="pmid">23294024</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goodkin</surname><given-names>H. P.</given-names></name><name><surname>Yeh</surname><given-names>J. L.</given-names></name><name><surname>Kapur</surname><given-names>J.</given-names></name></person-group> (<year>2005</year>). <article-title>Status epilepticus increases the intracellular accumulation of GABA<sub>A</sub> receptors</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>5511</fpage>–<lpage>5520</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0900-05.2005</pub-id><pub-id pub-id-type="pmid">15944379</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>Y.</given-names></name><name><surname>Chiu</surname><given-names>S. L.</given-names></name><name><surname>Liu</surname><given-names>B.</given-names></name><name><surname>Wu</surname><given-names>P. H.</given-names></name><name><surname>Delannoy</surname><given-names>M.</given-names></name><name><surname>Lin</surname><given-names>D. T.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Differential vesicular sorting of AMPA and GABA<sub>A</sub> receptors</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>113</volume>, <fpage>E922</fpage>–<lpage>E931</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1525726113</pub-id><pub-id pub-id-type="pmid">26839408</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gyenes</surname><given-names>M.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Gibbs</surname><given-names>T. T.</given-names></name><name><surname>Farb</surname><given-names>D. H.</given-names></name></person-group> (<year>1994</year>). <article-title>Phosphorylation factors control neurotransmitter and neuromodulator actions at the γ-aminobutyric acid type A receptor</article-title>. <source/>Mol. Pharmacol.
<volume>46</volume>, <fpage>542</fpage>–<lpage>549</lpage>. <pub-id pub-id-type="pmid">7935336</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>D. Y.</given-names></name><name><surname>Guan</surname><given-names>B. J.</given-names></name><name><surname>Wang</surname><given-names>Y. J.</given-names></name><name><surname>Hatzoglou</surname><given-names>M.</given-names></name><name><surname>Mu</surname><given-names>T. W.</given-names></name></person-group> (<year>2015</year>). <article-title>L-type calcium channel blockers enhance trafficking and function of epilepsy-associated α1 (D219N) subunits of GABA<sub>A</sub> receptors</article-title>. <source/>ACS Chem. Biol.
<volume>10</volume>, <fpage>2135</fpage>–<lpage>2148</lpage>. <pub-id pub-id-type="doi">10.1021/acschembio.5b00479</pub-id><pub-id pub-id-type="pmid">26168288</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Muhia</surname><given-names>M.</given-names></name><name><surname>Gerrow</surname><given-names>K.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Hirdes</surname><given-names>W.</given-names></name><name><surname>Tsukita</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Radixin regulates synaptic GABA<sub>A</sub> receptor density and is essential for reversal learning and short-term memory</article-title>. <source/>Nat. Commun.
<volume>6</volume>:<fpage>6872</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms7872</pub-id><pub-id pub-id-type="pmid">25891999</pub-id></mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herring</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Dillon</surname><given-names>G. H.</given-names></name><name><surname>Leidenheimer</surname><given-names>N. J.</given-names></name></person-group> (<year>2005</year>). <article-title>PKC modulation of GABA<sub>A</sub> receptor endocytosis and function is inhibited by mutation of a dileucine motif within the receptor β2 subunit</article-title>. <source/>Neuropharmacology
<volume>48</volume>, <fpage>181</fpage>–<lpage>194</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2004.09.015</pub-id><pub-id pub-id-type="pmid">15695157</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herring</surname><given-names>D.</given-names></name><name><surname>Huang</surname><given-names>R.</given-names></name><name><surname>Singh</surname><given-names>M.</given-names></name><name><surname>Robinson</surname><given-names>L. C.</given-names></name><name><surname>Dillon</surname><given-names>G. H.</given-names></name><name><surname>Leidenheimer</surname><given-names>N. J.</given-names></name></person-group> (<year>2003</year>). <article-title>Constitutive GABA<sub>A</sub> receptor endocytosis is dynamin-mediated and dependent on a dileucine AP2 adaptin-binding motif within the β2 subunit of the receptor</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>24046</fpage>–<lpage>24052</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M301420200</pub-id><pub-id pub-id-type="pmid">12707262</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hesdorffer</surname><given-names>D. C.</given-names></name><name><surname>Beck</surname><given-names>V.</given-names></name><name><surname>Begley</surname><given-names>C. E.</given-names></name><name><surname>Bishop</surname><given-names>M. L.</given-names></name><name><surname>Cushner-Weinstein</surname><given-names>S.</given-names></name><name><surname>Holmes</surname><given-names>G. L.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>research implications of the institute of medicine report, epilepsy across the spectrum: promoting health and understanding</article-title>. <source/>Epilepsia
<volume>54</volume>, <fpage>207</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12056</pub-id><pub-id pub-id-type="pmid">23294462</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hines</surname><given-names>R. M.</given-names></name><name><surname>Davies</surname><given-names>P. A.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Maguire</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Functional regulation of GABA<sub>A</sub> receptors in nervous system pathologies</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>22</volume>, <fpage>552</fpage>–<lpage>558</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2011.10.007</pub-id><pub-id pub-id-type="pmid">22036769</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hirose</surname><given-names>S.</given-names></name></person-group> (<year>2014</year>). <article-title>Mutant GABA<sub>A</sub> receptor subunits in genetic (idiopathic) epilepsy</article-title>. <source/>Prog. Brain Res.
<volume>213</volume>, <fpage>55</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1016/b978-0-444-63326-2.00003-x</pub-id><pub-id pub-id-type="pmid">25194483</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howell</surname><given-names>B. W.</given-names></name><name><surname>Smith</surname><given-names>K. M.</given-names></name></person-group> (<year>2019</year>). <article-title>Synaptic structural protein dysfunction leads to altered excitation inhibition ratios in models of autism spectrum disorder</article-title>. <source/>Pharmacol. Res.
<volume>139</volume>, <fpage>207</fpage>–<lpage>214</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2018.11.019</pub-id><pub-id pub-id-type="pmid">30465851</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>H. Z.</given-names></name><name><surname>Li</surname><given-names>Z. W.</given-names></name></person-group> (<year>1997</year>). <article-title>Modulation by adenosine of GABA-activated current in rat dorsal root ganglion neurons</article-title>. <source/>J. Physiol.
<volume>501</volume>, <fpage>67</fpage>–<lpage>75</lpage>. <pub-id pub-id-type="doi">10.1111/j.1469-7793.1997.067bo.x</pub-id><pub-id pub-id-type="pmid">9174995</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Hu</surname><given-names>N.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Three epilepsy-associated GABRG2 missense mutations at the γ+/β− interface disrupt GABA<sub>A</sub> receptor assembly and trafficking by similar mechanisms but to different extents</article-title>. <source/>Neurobiol. Dis.
<volume>68</volume>, <fpage>167</fpage>–<lpage>179</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.04.015</pub-id><pub-id pub-id-type="pmid">24798517</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>X.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Tian</surname><given-names>M.</given-names></name><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Verdier</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Overexpressing wild-type γ2 subunits rescued the seizure phenotype in Gabrg2<sup>+/Q390X</sup> Dravet syndrome mice</article-title>. <source/>Epilepsia
<volume>58</volume>, <fpage>1451</fpage>–<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1111/epi.13810</pub-id><pub-id pub-id-type="pmid">28586508</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>J. R.</given-names></name><name><surname>Melyn</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>EEG and seizures in autistic children and adolescents: further findings with therapeutic implications</article-title>. <source/>Clin. EEG Neurosci.
<volume>36</volume>, <fpage>15</fpage>–<lpage>20</lpage>. <pub-id pub-id-type="doi">10.1177/155005940503600105</pub-id><pub-id pub-id-type="pmid">15683193</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ishii</surname><given-names>A.</given-names></name><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Schornak</surname><given-names>C. C.</given-names></name><name><surname>Hernandez</surname><given-names>C. C.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Watkins</surname><given-names>J. C.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>A <italic>de novo</italic> missense mutation of <italic>GABRB2</italic> causes early myoclonic encephalopathy</article-title>. <source/>J. Med. Genet.
<volume>54</volume>, <fpage>202</fpage>–<lpage>211</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2016-104083</pub-id><pub-id pub-id-type="pmid">27789573</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Bogdanov</surname><given-names>Y. D.</given-names></name><name><surname>Magnus</surname><given-names>C.</given-names></name><name><surname>Saliba</surname><given-names>R. S.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Haydon</surname><given-names>P. G.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Gephyrin regulates the cell surface dynamics of synaptic GABA<sub>A</sub> receptors</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>10469</fpage>–<lpage>10478</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2267-05.2005</pub-id><pub-id pub-id-type="pmid">16280585</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Jurd</surname><given-names>R.</given-names></name></person-group> (<year>2008</year>). <article-title>GABA<sub>A</sub> receptor trafficking and its role in the dynamic modulation of neuronal inhibition</article-title>. <source/>Nat. Rev. Neurosci.
<volume>9</volume>, <fpage>331</fpage>–<lpage>343</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2370</pub-id><pub-id pub-id-type="pmid">18382465</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacobs</surname><given-names>M. P.</given-names></name><name><surname>Leblanc</surname><given-names>G. G.</given-names></name><name><surname>Brooks-Kayal</surname><given-names>A.</given-names></name><name><surname>Jensen</surname><given-names>F. E.</given-names></name><name><surname>Lowenstein</surname><given-names>D. H.</given-names></name><name><surname>Noebels</surname><given-names>J. L.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Curing epilepsy: progress and future directions</article-title>. <source/>Epilepsy Behav.
<volume>14</volume>, <fpage>438</fpage>–<lpage>445</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2009.02.036</pub-id><pub-id pub-id-type="pmid">19341977</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jaenisch</surname><given-names>N.</given-names></name><name><surname>Witte</surname><given-names>O. W.</given-names></name><name><surname>Frahm</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Downregulation of potassium chloride cotransporter KCC2 after transient focal cerebral ischemia</article-title>. <source/>Stroke
<volume>41</volume>, <fpage>e151</fpage>–<lpage>e159</lpage>. <pub-id pub-id-type="doi">10.1161/STROKEAHA.109.570424</pub-id><pub-id pub-id-type="pmid">20044519</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jedlicka</surname><given-names>P.</given-names></name><name><surname>Deller</surname><given-names>T.</given-names></name><name><surname>Gutkin</surname><given-names>B. S.</given-names></name><name><surname>Backus</surname><given-names>K. H.</given-names></name></person-group> (<year>2011</year>). <article-title>Activity-dependent intracellular chloride accumulation and diffusion controls GABA<sub>A</sub> receptor-mediated synaptic transmission</article-title>. <source/>Hippocampus
<volume>21</volume>, <fpage>885</fpage>–<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1002/hipo.20804</pub-id><pub-id pub-id-type="pmid">20575006</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jenks</surname><given-names>S.</given-names></name><name><surname>Volkers</surname><given-names>N.</given-names></name></person-group> (<year>1992</year>). <article-title>Razors and refrigerators and reindeer—oh my!</article-title>
<source/>J. Natl. Cancer Inst.
<volume>84</volume>:<fpage>1863</fpage>. <pub-id pub-id-type="doi">10.1093/jnci/84.24.1863</pub-id><pub-id pub-id-type="pmid">1460669</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>Y. H.</given-names></name><name><surname>Donier</surname><given-names>E.</given-names></name><name><surname>Martinez</surname><given-names>A.</given-names></name><name><surname>Garret</surname><given-names>M.</given-names></name><name><surname>Toulmé</surname><given-names>E.</given-names></name><name><surname>Boué-Grabot</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Cross-talk between P2X4 and γ-aminobutyric acid, type A receptors determines synaptic efficacy at a central synapse</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>19993</fpage>–<lpage>20004</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m111.231324</pub-id><pub-id pub-id-type="pmid">21482824</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahle</surname><given-names>K. T.</given-names></name><name><surname>Merner</surname><given-names>N. D.</given-names></name><name><surname>Friedel</surname><given-names>P.</given-names></name><name><surname>Silayeva</surname><given-names>L.</given-names></name><name><surname>Liang</surname><given-names>B.</given-names></name><name><surname>Khanna</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy</article-title>. <source/>EMBO Rep.
<volume>15</volume>, <fpage>766</fpage>–<lpage>774</lpage>. <pub-id pub-id-type="doi">10.15252/embr.201438840</pub-id><pub-id pub-id-type="pmid">24928908</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaila</surname><given-names>K.</given-names></name><name><surname>Price</surname><given-names>T. J.</given-names></name><name><surname>Payne</surname><given-names>J. A.</given-names></name><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Voipio</surname><given-names>J.</given-names></name></person-group> (<year>2014</year>). <article-title>Cation-chloride cotransporters in neuronal development, plasticity and disease</article-title>. <source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>637</fpage>–<lpage>654</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3819</pub-id><pub-id pub-id-type="pmid">25234263</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Jang</surname><given-names>I. S.</given-names></name><name><surname>Yamaguchi</surname><given-names>T.</given-names></name><name><surname>Nagahama</surname><given-names>H.</given-names></name><name><surname>Yoshimura</surname><given-names>K.</given-names></name><name><surname>Hidaka</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2002</year>). <article-title>Role of the PLC-related, catalytically inactive protein p130 in GABA<sub>A</sub> receptor function</article-title>. <source/>EMBO J.
<volume>21</volume>, <fpage>1004</fpage>–<lpage>1011</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/21.5.1004</pub-id><pub-id pub-id-type="pmid">11867528</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>J. Q.</given-names></name><name><surname>Shen</surname><given-names>W.</given-names></name><name><surname>Zhou</surname><given-names>C.</given-names></name><name><surname>Xu</surname><given-names>D.</given-names></name><name><surname>Macdonald</surname><given-names>R. L.</given-names></name></person-group> (<year>2015</year>). <article-title>The human epilepsy mutation GABRG2(Q390X) causes chronic subunit accumulation and neurodegeneration</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>988</fpage>–<lpage>996</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4024</pub-id><pub-id pub-id-type="pmid">26005849</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karran</surname><given-names>E.</given-names></name><name><surname>De Strooper</surname><given-names>B.</given-names></name></person-group> (<year>2016</year>). <article-title>The amyloid cascade hypothesis: are we poised for success or failure?</article-title>
<source/>J. Neurosurg.
<volume>139</volume>, <fpage>237</fpage>–<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13632</pub-id><pub-id pub-id-type="pmid">27255958</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2004a</year>). <article-title>Association of GRIP1 with a GABA<sub>A</sub> receptor associated protein suggests a role for GRIP1 at inhibitory synapses</article-title>. <source/>Biochem. Pharmacol.
<volume>68</volume>, <fpage>1649</fpage>–<lpage>1654</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2004.07.028</pub-id><pub-id pub-id-type="pmid">15451408</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Bogdanov</surname><given-names>Y. D.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><etal></etal></person-group>. (<year>2004b</year>). <article-title>Huntingtin-associated protein 1 regulates inhibitory synaptic transmission by modulating γ-aminobutyric acid type A receptor membrane trafficking</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>101</volume>, <fpage>12736</fpage>–<lpage>12741</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0401860101</pub-id><pub-id pub-id-type="pmid">15310851</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Honing</surname><given-names>S.</given-names></name><name><surname>Bogdanov</surname><given-names>Y.</given-names></name><name><surname>McAinsh</surname><given-names>K.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Phospho-dependent binding of the clathrin AP2 adaptor complex to GABA<sub>A</sub> receptors regulates the efficacy of inhibitory synaptic transmission</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>14871</fpage>–<lpage>14876</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0506653102</pub-id><pub-id pub-id-type="pmid">16192353</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Kukhtina</surname><given-names>V.</given-names></name><name><surname>Vahedi-Faridi</surname><given-names>A.</given-names></name><name><surname>Gu</surname><given-names>Z.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Regulation of synaptic inhibition by phospho-dependent binding of the AP2 complex to a YECL motif in the GABA<sub>A</sub> receptor γ2 subunit</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>105</volume>, <fpage>3616</fpage>–<lpage>3621</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0707920105</pub-id><pub-id pub-id-type="pmid">18305175</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Delmas</surname><given-names>P.</given-names></name><name><surname>Jovanovic</surname><given-names>J. N.</given-names></name><name><surname>Brown</surname><given-names>D. A.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2000</year>). <article-title>Constitutive endocytosis of GABA<sub>A</sub> receptors by an association with the adaptin AP2 complex modulates inhibitory synaptic currents in hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>20</volume>, <fpage>7972</fpage>–<lpage>7977</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.20-21-07972.2000</pub-id><pub-id pub-id-type="pmid">11050117</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>McAinsh</surname><given-names>K.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2002</year>). <article-title>Mechanisms of GABA<sub>A</sub> receptor assembly and trafficking: implications for the modulation of inhibitory neurotransmission</article-title>. <source/>Mol. Neurobiol.
<volume>26</volume>, <fpage>251</fpage>–<lpage>268</lpage>. <pub-id pub-id-type="doi">10.1385/mn:26:2-3:251</pub-id><pub-id pub-id-type="pmid">12428759</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Schiavo</surname><given-names>G.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Olsen</surname><given-names>R.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The subcellular distribution of GABARAP and its ability to interact with NSF suggest a role for this protein in the intracellular transport of GABA<sub>A</sub> receptors</article-title>. <source/>Mol. Cell. Neurosci.
<volume>18</volume>, <fpage>13</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1006/mcne.2001.1005</pub-id><pub-id pub-id-type="pmid">11461150</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kolc</surname><given-names>K. L.</given-names></name><name><surname>Sadleir</surname><given-names>L. G.</given-names></name><name><surname>Scheffer</surname><given-names>I. E.</given-names></name><name><surname>Ivancevic</surname><given-names>A.</given-names></name><name><surname>Roberts</surname><given-names>R.</given-names></name><name><surname>Pham</surname><given-names>D. H.</given-names></name><etal></etal></person-group>. (<year>2019</year>). <article-title>A systematic review and meta-analysis of 271 PCDH19-variant individuals identifies psychiatric comorbidities and association of seizure onset and disease severity</article-title>. <source/>Mol. Psychiatry
<volume>24</volume>, <fpage>241</fpage>–<lpage>251</lpage>. <pub-id pub-id-type="doi">10.1038/s41380-018-0066-9</pub-id><pub-id pub-id-type="pmid">29892053</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kosinovsky</surname><given-names>B.</given-names></name><name><surname>Hermon</surname><given-names>S.</given-names></name><name><surname>Yoran-Hegesh</surname><given-names>R.</given-names></name><name><surname>Golomb</surname><given-names>A.</given-names></name><name><surname>Senecky</surname><given-names>Y.</given-names></name><name><surname>Goez</surname><given-names>H.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>The yield of laboratory investigations in children with infantile autism</article-title>. <source/>J. Neural Transm.
<volume>112</volume>, <fpage>587</fpage>–<lpage>596</lpage>. <pub-id pub-id-type="doi">10.1007/s00702-004-0198-8</pub-id><pub-id pub-id-type="pmid">15503196</pub-id></mixed-citation>
</ref>
<ref id="B98">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kozinetz</surname><given-names>C. A.</given-names></name><name><surname>Skender</surname><given-names>M. L.</given-names></name><name><surname>MacNaughton</surname><given-names>N.</given-names></name><name><surname>Almes</surname><given-names>M. J.</given-names></name><name><surname>Schultz</surname><given-names>R. J.</given-names></name><name><surname>Percy</surname><given-names>A. K.</given-names></name><etal></etal></person-group>. (<year>1993</year>). <article-title>Epidemiology of Rett syndrome: a population-based registry</article-title>. <source/>Pediatrics
<volume>91</volume>, <fpage>445</fpage>–<lpage>450</lpage>. <pub-id pub-id-type="pmid">8424025</pub-id></mixed-citation>
</ref>
<ref id="B99">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwakowsky</surname><given-names>A.</given-names></name><name><surname>Calvo-Flores Guzman</surname><given-names>B.</given-names></name><name><surname>Govindpani</surname><given-names>K.</given-names></name><name><surname>Waldvogel</surname><given-names>H. J.</given-names></name><name><surname>Faull</surname><given-names>R. L.</given-names></name></person-group> (<year>2018</year>). <article-title>γ-aminobutyric acid A receptors in Alzheimer’s disease: highly localized remodeling of a complex and diverse signaling pathway</article-title>. <source/>Neural Regen. Res.
<volume>13</volume>, <fpage>1362</fpage>–<lpage>1363</lpage>. <pub-id pub-id-type="doi">10.4103/1673-5374.235240</pub-id><pub-id pub-id-type="pmid">30106045</pub-id></mixed-citation>
</ref>
<ref id="B100">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>S.</given-names></name><name><surname>Kim</surname><given-names>K.</given-names></name><name><surname>Zhou</surname><given-names>Z. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Role of ACh-GABA cotransmission in detecting image motion and motion direction</article-title>. <source/>Neuron
<volume>68</volume>, <fpage>1159</fpage>–<lpage>1172</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2010.11.031</pub-id><pub-id pub-id-type="pmid">21172616</pub-id></mixed-citation>
</ref>
<ref id="B101">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leil</surname><given-names>T. A.</given-names></name><name><surname>Chen</surname><given-names>Z. W.</given-names></name><name><surname>Chang</surname><given-names>C. S.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>2004</year>). <article-title>GABA<sub>A</sub> receptor-associated protein traffics GABA<sub>A</sub> receptors to the plasma membrane in neurons</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>11429</fpage>–<lpage>11438</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3355-04.2004</pub-id><pub-id pub-id-type="pmid">15601949</pub-id></mixed-citation>
</ref>
<ref id="B104">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X. J.</given-names></name><name><surname>Li</surname><given-names>S. H.</given-names></name><name><surname>Sharp</surname><given-names>A. H.</given-names></name><name><surname>Nucifora</surname><given-names>F. C.</given-names><suffix>Jr.</suffix></name><name><surname>Schilling</surname><given-names>G.</given-names></name><name><surname>Lanahan</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>1995</year>). <article-title>A huntingtin-associated protein enriched in brain with implications for pathology</article-title>. <source/>Nature
<volume>378</volume>, <fpage>398</fpage>–<lpage>402</lpage>. <pub-id pub-id-type="doi">10.1038/378398a0</pub-id><pub-id pub-id-type="pmid">7477378</pub-id></mixed-citation>
</ref>
<ref id="B103">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>R. W.</given-names></name><name><surname>Serwanski</surname><given-names>D. R.</given-names></name><name><surname>Miralles</surname><given-names>C. P.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Charych</surname><given-names>E.</given-names></name><name><surname>Riquelme</surname><given-names>R.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>GRIP1 in GABAergic synapses</article-title>. <source/>J. Comp. Neurol.
<volume>488</volume>, <fpage>11</fpage>–<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1002/cne.20566</pub-id><pub-id pub-id-type="pmid">15912503</pub-id></mixed-citation>
</ref>
<ref id="B102">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Zhang</surname><given-names>W.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Howrigan</surname><given-names>D. P.</given-names></name><name><surname>Wilkinson</surname><given-names>B.</given-names></name><name><surname>Souaiaia</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2017a</year>). <article-title>Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders</article-title>. <source/>Nat. Neurosci.
<volume>20</volume>, <fpage>1150</fpage>–<lpage>1161</lpage>. <pub-id pub-id-type="doi">10.1038/nn.4594</pub-id><pub-id pub-id-type="pmid">28671696</pub-id></mixed-citation>
</ref>
<ref id="B105">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Peng</surname><given-names>L.</given-names></name><name><surname>Zhao</surname><given-names>Y.</given-names></name></person-group> (<year>2017b</year>). <article-title>Reduced protein expressions of cytomembrane GABA<sub>A</sub>Rβ3 at different postnatal developmental stages of rats exposed prenatally to valproic acid</article-title>. <source/>Brain Res.
<volume>1671</volume>, <fpage>33</fpage>–<lpage>42</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2017.06.018</pub-id><pub-id pub-id-type="pmid">28641949</pub-id></mixed-citation>
</ref>
<ref id="B106">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Limon</surname><given-names>A.</given-names></name><name><surname>Reyes-Ruiz</surname><given-names>J. M.</given-names></name><name><surname>Miledi</surname><given-names>R.</given-names></name></person-group> (<year>2012</year>). <article-title>Loss of functional GABA<sub>A</sub> receptors in the Alzheimer diseased brain</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>109</volume>, <fpage>10071</fpage>–<lpage>10076</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1204606109</pub-id><pub-id pub-id-type="pmid">22691495</pub-id></mixed-citation>
</ref>
<ref id="B300">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>F.</given-names></name><name><surname>Wan</surname><given-names>Q.</given-names></name><name><surname>Pristupa</surname><given-names>Z. B.</given-names></name><name><surname>Yu</surname><given-names>X.-M.</given-names></name><name><surname>Wang</surname><given-names>Y. T.</given-names></name><name><surname>Niznik</surname><given-names>H. B.</given-names></name></person-group> (<year>2000</year>). <article-title>Direct protein-protein coupling enables cross-talk between dopamine D5 and γ-aminobutyric acid A receptors</article-title>. <source/>Nature
<volume>403</volume>, <fpage>274</fpage>–<lpage>280</lpage>. <pub-id pub-id-type="doi">10.1038/35002014</pub-id><pub-id pub-id-type="pmid">10659839</pub-id></mixed-citation>
</ref>
<ref id="B107">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loebrich</surname><given-names>S.</given-names></name><name><surname>Bähring</surname><given-names>R.</given-names></name><name><surname>Katsuno</surname><given-names>T.</given-names></name><name><surname>Tsukita</surname><given-names>S.</given-names></name><name><surname>Kneussel</surname><given-names>M.</given-names></name></person-group> (<year>2006</year>). <article-title>Activated radixin is essential for GABA<sub>A</sub> receptor α5 subunit anchoring at the actin cytoskeleton</article-title>. <source/>EMBO J.
<volume>25</volume>, <fpage>987</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1038/sj.emboj.7600995</pub-id><pub-id pub-id-type="pmid">16467845</pub-id></mixed-citation>
</ref>
<ref id="B108">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loscher</surname><given-names>W.</given-names></name><name><surname>Brandt</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Prevention or modification of epileptogenesis after brain insults: experimental approaches and translational research</article-title>. <source/>Pharmacol. Rev.
<volume>62</volume>, <fpage>668</fpage>–<lpage>700</lpage>. <pub-id pub-id-type="doi">10.1124/pr.110.003046</pub-id><pub-id pub-id-type="pmid">21079040</pub-id></mixed-citation>
</ref>
<ref id="B109">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marsden</surname><given-names>K. C.</given-names></name><name><surname>Beattie</surname><given-names>J. B.</given-names></name><name><surname>Friedenthal</surname><given-names>J.</given-names></name><name><surname>Carroll</surname><given-names>R. C.</given-names></name></person-group> (<year>2007</year>). <article-title>NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABA<sub>A</sub> receptors</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>14326</fpage>–<lpage>14337</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4433-07.2007</pub-id><pub-id pub-id-type="pmid">18160640</pub-id></mixed-citation>
</ref>
<ref id="B110">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mattina</surname><given-names>T.</given-names></name><name><surname>Perrotta</surname><given-names>C. S.</given-names></name><name><surname>Grossfeld</surname><given-names>P.</given-names></name></person-group> (<year>2009</year>). <article-title>Jacobsen syndrome</article-title>. <source/>Orphanet J. Rare Dis.
<volume>4</volume>:<fpage>9</fpage>. <pub-id pub-id-type="doi">10.1186/1750-1172-4-9</pub-id><pub-id pub-id-type="pmid">19267933</pub-id></mixed-citation>
</ref>
<ref id="B111">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McClory</surname><given-names>H.</given-names></name><name><surname>Williams</surname><given-names>D.</given-names></name><name><surname>Sapp</surname><given-names>E.</given-names></name><name><surname>Gatune</surname><given-names>L. W.</given-names></name><name><surname>Wang</surname><given-names>P.</given-names></name><name><surname>DiFiglia</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Glucose transporter 3 is a rab11-dependent trafficking cargo and its transport to the cell surface is reduced in neurons of CAG140 Huntington’s disease mice</article-title>. <source/>Acta Neuropathol. Commun.
<volume>2</volume>:<fpage>179</fpage>. <pub-id pub-id-type="doi">10.1186/s40478-014-0178-7</pub-id><pub-id pub-id-type="pmid">25526803</pub-id></mixed-citation>
</ref>
<ref id="B112">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCormick</surname><given-names>D. A.</given-names></name><name><surname>Contreras</surname><given-names>D.</given-names></name></person-group> (<year>2001</year>). <article-title>On the cellular and network bases of epileptic seizures</article-title>. <source/>Annu. Rev. Physiol.
<volume>63</volume>, <fpage>815</fpage>–<lpage>846</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.physiol.63.1.815</pub-id><pub-id pub-id-type="pmid">11181977</pub-id></mixed-citation>
</ref>
<ref id="B113">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDade</surname><given-names>D. M.</given-names></name><name><surname>Conway</surname><given-names>A. M.</given-names></name><name><surname>James</surname><given-names>A. B.</given-names></name><name><surname>Morris</surname><given-names>B. J.</given-names></name></person-group> (<year>2009</year>). <article-title>Activity-dependent gene transcription as a long-term influence on receptor signalling</article-title>. <source/>Biochem. Soc. Trans.
<volume>37</volume>, <fpage>1375</fpage>–<lpage>1377</lpage>. <pub-id pub-id-type="doi">10.1042/bst0371375</pub-id><pub-id pub-id-type="pmid">19909279</pub-id></mixed-citation>
</ref>
<ref id="B114">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDonald</surname><given-names>B. J.</given-names></name><name><surname>Amato</surname><given-names>A.</given-names></name><name><surname>Connolly</surname><given-names>C. N.</given-names></name><name><surname>Benke</surname><given-names>D.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>1998</year>). <article-title>Adjacent phosphorylation sites on GABA<sub>A</sub> receptor β subunits determine regulation by cAMP-dependent protein kinase</article-title>. <source/>Nat. Neurosci.
<volume>1</volume>, <fpage>23</fpage>–<lpage>28</lpage>. <pub-id pub-id-type="doi">10.1038/223</pub-id><pub-id pub-id-type="pmid">10195104</pub-id></mixed-citation>
</ref>
<ref id="B115">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meder</surname><given-names>D.</given-names></name><name><surname>Herz</surname><given-names>D. M.</given-names></name><name><surname>Rowe</surname><given-names>J. B.</given-names></name><name><surname>Lehericy</surname><given-names>S.</given-names></name><name><surname>Siebner</surname><given-names>H. R.</given-names></name></person-group> (<year>2018</year>). <article-title>The role of dopamine in the brain—Lessons learned from Parkinson’s disease</article-title>. <source/>Neuroimage [Epub ahead of print]. <pub-id pub-id-type="doi">10.1016/j.neuroimage.2018.11.021</pub-id><pub-id pub-id-type="pmid">30465864</pub-id></mixed-citation>
</ref>
<ref id="B116">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mele</surname><given-names>M.</given-names></name><name><surname>Aspromonte</surname><given-names>M. C.</given-names></name><name><surname>Duarte</surname><given-names>C. B.</given-names></name></person-group> (<year>2017</year>). <article-title>Downregulation of GABA<sub>A</sub> receptor recycling mediated by HAP1 contributes to neuronal death in <italic>in vitro</italic> brain ischemia</article-title>. <source/>Mol. Neurobiol.
<volume>54</volume>, <fpage>45</fpage>–<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1007/s12035-015-9661-9</pub-id><pub-id pub-id-type="pmid">26732589</pub-id></mixed-citation>
</ref>
<ref id="B117">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mele</surname><given-names>M.</given-names></name><name><surname>Leal</surname><given-names>G.</given-names></name><name><surname>Duarte</surname><given-names>C. B.</given-names></name></person-group> (<year>2016</year>). <article-title>Role of GABA<sub>A</sub>R trafficking in the plasticity of inhibitory synapses</article-title>. <source/>J. Neurochem.
<volume>139</volume>, <fpage>997</fpage>–<lpage>1018</lpage>. <pub-id pub-id-type="doi">10.1111/jnc.13742</pub-id><pub-id pub-id-type="pmid">27424566</pub-id></mixed-citation>
</ref>
<ref id="B118">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mele</surname><given-names>M.</given-names></name><name><surname>Ribeiro</surname><given-names>L.</given-names></name><name><surname>Inácio</surname><given-names>A. R.</given-names></name><name><surname>Wieloch</surname><given-names>T.</given-names></name><name><surname>Duarte</surname><given-names>C. B.</given-names></name></person-group> (<year>2014</year>). <article-title>GABA<sub>A</sub> receptor dephosphorylation followed by internalization is coupled to neuronal death in <italic>in vitro</italic> ischemia</article-title>. <source/>Neurobiol. Dis.
<volume>65</volume>, <fpage>220</fpage>–<lpage>232</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2014.01.019</pub-id><pub-id pub-id-type="pmid">24513087</pub-id></mixed-citation>
</ref>
<ref id="B119">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2007</year>). <article-title>GABA<sub>A</sub> receptors: properties and trafficking</article-title>. <source/>Crit. Rev. Biochem. Mol. Biol.
<volume>42</volume>, <fpage>3</fpage>–<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1080/10409230601146219</pub-id><pub-id pub-id-type="pmid">17364682</pub-id></mixed-citation>
</ref>
<ref id="B120">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mielke</surname><given-names>J. G.</given-names></name><name><surname>Wang</surname><given-names>Y. T.</given-names></name></person-group> (<year>2005</year>). <article-title>Insulin exerts neuroprotection by counteracting the decrease in cell-surface GABA receptors following oxygen-glucose deprivation in cultured cortical neurons</article-title>. <source/>J. Neurochem.
<volume>92</volume>, <fpage>103</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1111/j.1471-4159.2004.02841.x</pub-id><pub-id pub-id-type="pmid">15606900</pub-id></mixed-citation>
</ref>
<ref id="B121">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Gorrie</surname><given-names>G. H.</given-names></name><name><surname>Amato</surname><given-names>A.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>1995</year>). <article-title>Modulation of GABA<sub>A</sub> receptors by tyrosine phosphorylation</article-title>. <source/>Nature
<volume>377</volume>, <fpage>344</fpage>–<lpage>348</lpage>. <pub-id pub-id-type="doi">10.1038/377344a0</pub-id><pub-id pub-id-type="pmid">7566089</pub-id></mixed-citation>
</ref>
<ref id="B122">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>MacAskill</surname><given-names>A. F.</given-names></name><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Griffin</surname><given-names>L. D.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2010</year>). <article-title>NMDA receptors regulate GABA<sub>A</sub> receptor lateral mobility and clustering at inhibitory synapses through serine 327 on the γ2 subunit</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>107</volume>, <fpage>16679</fpage>–<lpage>16684</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1000589107</pub-id><pub-id pub-id-type="pmid">20823221</pub-id></mixed-citation>
</ref>
<ref id="B123">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Kretschmannova</surname><given-names>K.</given-names></name><name><surname>Gouzer</surname><given-names>G.</given-names></name><name><surname>Maric</surname><given-names>H. M.</given-names></name><name><surname>Ramsden</surname><given-names>S.</given-names></name><name><surname>Tretter</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>The residence time of GABA<sub>A</sub>Rs at inhibitory synapses is determined by direct binding of the receptor α1 subunit to gephyrin</article-title>. <source/>J. Neurosci.
<volume>31</volume>, <fpage>14677</fpage>–<lpage>14687</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.2001-11.2011</pub-id><pub-id pub-id-type="pmid">21994384</pub-id></mixed-citation>
</ref>
<ref id="B124">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murakami</surname><given-names>T.</given-names></name><name><surname>Shoji</surname><given-names>M.</given-names></name><name><surname>Imai</surname><given-names>Y.</given-names></name><name><surname>Inoue</surname><given-names>H.</given-names></name><name><surname>Kawarabayashi</surname><given-names>T.</given-names></name><name><surname>Matsubara</surname><given-names>E.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Pael-R is accumulated in Lewy bodies of Parkinson’s disease</article-title>. <source/>Ann. Neurol.
<volume>55</volume>, <fpage>439</fpage>–<lpage>442</lpage>. <pub-id pub-id-type="doi">10.1002/ana.20064</pub-id><pub-id pub-id-type="pmid">14991825</pub-id></mixed-citation>
</ref>
<ref id="B125">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>T.</given-names></name><name><surname>Arima-Yoshida</surname><given-names>F.</given-names></name><name><surname>Sakaue</surname><given-names>F.</given-names></name><name><surname>Nasu-Nishimura</surname><given-names>Y.</given-names></name><name><surname>Takeda</surname><given-names>Y.</given-names></name><name><surname>Matsuura</surname><given-names>K.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title><italic>PX-RICS</italic>-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABA<sub>A</sub> receptor trafficking</article-title>. <source/>Nat. Commun.
<volume>7</volume>:<fpage>10861</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms10861</pub-id><pub-id pub-id-type="pmid">26979507</pub-id></mixed-citation>
</ref>
<ref id="B126">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakamura</surname><given-names>Y.</given-names></name><name><surname>Darnieder</surname><given-names>L. M.</given-names></name><name><surname>Deeb</surname><given-names>T. Z.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2015</year>). <article-title>Regulation of GABA<sub>A</sub>Rs by phosphorylation</article-title>. <source/>Adv. Pharmacol.
<volume>72</volume>, <fpage>97</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1016/bs.apha.2014.11.008</pub-id><pub-id pub-id-type="pmid">25600368</pub-id></mixed-citation>
</ref>
<ref id="B127">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naylor</surname><given-names>D. E.</given-names></name><name><surname>Liu</surname><given-names>H.</given-names></name><name><surname>Wasterlain</surname><given-names>C. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Trafficking of GABA<sub>A</sub> receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus</article-title>. <source/>J. Neurosci.
<volume>25</volume>, <fpage>7724</fpage>–<lpage>7733</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4944-04.2005</pub-id><pub-id pub-id-type="pmid">16120773</pub-id></mixed-citation>
</ref>
<ref id="B128">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>L. A.</given-names></name></person-group> (<year>1990</year>). <article-title>Plaque and gingivitis in children with cerebral palsy: relation to CP-diagnosis, mental and motor handicap</article-title>. <source/>Tandlaegernes Tidsskr.
<volume>5</volume>, <fpage>316</fpage>–<lpage>320</lpage>. <pub-id pub-id-type="pmid">2151422</pub-id></mixed-citation>
</ref>
<ref id="B129">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nishikawa</surname><given-names>K.</given-names></name><name><surname>Jenkins</surname><given-names>A.</given-names></name><name><surname>Paraskevakis</surname><given-names>I.</given-names></name><name><surname>Harrison</surname><given-names>N. L.</given-names></name></person-group> (<year>2002</year>). <article-title>Volatile anesthetic actions on the GABA<sub>A</sub> receptors: contrasting effects of α 1(S270) and β 2(N265) point mutations</article-title>. <source/>Neuropharmacology
<volume>42</volume>, <fpage>337</fpage>–<lpage>345</lpage>. <pub-id pub-id-type="doi">10.1016/s0028-3908(01)00189-7</pub-id><pub-id pub-id-type="pmid">11897112</pub-id></mixed-citation>
</ref>
<ref id="B130">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Cull-Candy</surname><given-names>S.</given-names></name><name><surname>Farrant</surname><given-names>M.</given-names></name></person-group> (<year>1997</year>). <article-title>Differences in synaptic GABA<sub>A</sub> receptor number underlie variation in GABA mini amplitude</article-title>. <source/>Neuron
<volume>19</volume>, <fpage>697</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(00)80382-7</pub-id><pub-id pub-id-type="pmid">9331359</pub-id></mixed-citation>
</ref>
<ref id="B131">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Hájos</surname><given-names>N.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name><name><surname>Mody</surname><given-names>I.</given-names></name></person-group> (<year>1998a</year>). <article-title>Increased number of synaptic GABA<sub>A</sub> receptors underlies potentiation at hippocampal inhibitory synapses</article-title>. <source/>Nature
<volume>395</volume>, <fpage>172</fpage>–<lpage>177</lpage>. <pub-id pub-id-type="doi">10.1038/25999</pub-id><pub-id pub-id-type="pmid">9744275</pub-id></mixed-citation>
</ref>
<ref id="B132">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>1998b</year>). <article-title>Segregation of different GABA<sub>A</sub> receptors to synaptic and extrasynaptic membranes of cerebellar granule cells</article-title>. <source/>J. Neurosci.
<volume>18</volume>, <fpage>1693</fpage>–<lpage>1703</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.18-05-01693.1998</pub-id><pub-id pub-id-type="pmid">9464994</pub-id></mixed-citation>
</ref>
<ref id="B133">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nusser</surname><given-names>Z.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Stephenson</surname><given-names>F. A.</given-names></name><name><surname>Somogyi</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>The α 6 subunit of the GABA<sub>A</sub> receptor is concentrated in both inhibitory and excitatory synapses on cerebellar granule cells</article-title>. <source/>J. Neurosci.
<volume>16</volume>, <fpage>103</fpage>–<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.16-01-00103.1996</pub-id><pub-id pub-id-type="pmid">8613776</pub-id></mixed-citation>
</ref>
<ref id="B134">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsson</surname><given-names>I.</given-names></name><name><surname>Steffenburg</surname><given-names>S.</given-names></name><name><surname>Gillberg</surname><given-names>C.</given-names></name></person-group> (<year>1988</year>). <article-title>Epilepsy in autism and autisticlike conditions. A population-based study</article-title>. <source/>Arch. Neurol.
<volume>45</volume>, <fpage>666</fpage>–<lpage>668</lpage>. <pub-id pub-id-type="doi">10.1001/archneur.1988.00520300086024</pub-id><pub-id pub-id-type="pmid">3369974</pub-id></mixed-citation>
</ref>
<ref id="B135">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Papp</surname><given-names>E.</given-names></name><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Kaila</surname><given-names>K.</given-names></name><name><surname>Freund</surname><given-names>T. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Relationship between neuronal vulnerability and potassium-chloride cotransporter 2 immunoreactivity in hippocampus following transient forebrain ischemia</article-title>. <source/>Neuroscience
<volume>154</volume>, <fpage>677</fpage>–<lpage>689</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.03.072</pub-id><pub-id pub-id-type="pmid">18472345</pub-id></mixed-citation>
</ref>
<ref id="B136">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parihar</surname><given-names>M. S.</given-names></name><name><surname>Brewer</surname><given-names>G. J.</given-names></name></person-group> (<year>2010</year>). <article-title>Amyloid-β as a modulator of synaptic plasticity</article-title>. <source/>J. Alzheimers Dis.
<volume>22</volume>, <fpage>741</fpage>–<lpage>763</lpage>. <pub-id pub-id-type="doi">10.3233/jad-2010-101020</pub-id><pub-id pub-id-type="pmid">20847424</pub-id></mixed-citation>
</ref>
<ref id="B137">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pennacchietti</surname><given-names>F.</given-names></name><name><surname>Vascon</surname><given-names>S.</given-names></name><name><surname>Nieus</surname><given-names>T.</given-names></name><name><surname>Rosillo</surname><given-names>C.</given-names></name><name><surname>Das</surname><given-names>S.</given-names></name><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Nanoscale molecular reorganization of the inhibitory postsynaptic density is a determinant of GABAergic synaptic potentiation</article-title>. <source/>J. Neurosci.
<volume>37</volume>, <fpage>1747</fpage>–<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0514-16.2016</pub-id><pub-id pub-id-type="pmid">28073939</pub-id></mixed-citation>
</ref>
<ref id="B138">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petrini</surname><given-names>E. M.</given-names></name><name><surname>Ravasenga</surname><given-names>T.</given-names></name><name><surname>Hausrat</surname><given-names>T. J.</given-names></name><name><surname>Iurilli</surname><given-names>G.</given-names></name><name><surname>Olcese</surname><given-names>U.</given-names></name><name><surname>Racine</surname><given-names>V.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Synaptic recruitment of gephyrin regulates surface GABA<sub>A</sub> receptor dynamics for the expression of inhibitory LTP</article-title>. <source/>Nat. Commun.
<volume>5</volume>:<fpage>3921</fpage>. <pub-id pub-id-type="doi">10.1038/ncomms4921</pub-id><pub-id pub-id-type="pmid">24894704</pub-id></mixed-citation>
</ref>
<ref id="B139">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pinborg</surname><given-names>L. H.</given-names></name><name><surname>Videbaek</surname><given-names>C.</given-names></name><name><surname>Hasselbalch</surname><given-names>S. G.</given-names></name><name><surname>Sorensen</surname><given-names>S. A.</given-names></name><name><surname>Wagner</surname><given-names>A.</given-names></name><name><surname>Paulson</surname><given-names>O. B.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>Benzodiazepine receptor quantification in Huntington’s disease with [(123)I]omazenil and SPECT</article-title>. <source/>J. Neurol. Neurosurg. Psychiatry
<volume>70</volume>, <fpage>657</fpage>–<lpage>661</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.70.5.657</pub-id><pub-id pub-id-type="pmid">11309461</pub-id></mixed-citation>
</ref>
<ref id="B140">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pizzarelli</surname><given-names>R.</given-names></name><name><surname>Cherubini</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Alterations of GABAergic signaling in autism spectrum disorders</article-title>. <source/>Neural Plast.
<volume>2011</volume>:<fpage>297153</fpage>. <pub-id pub-id-type="doi">10.1155/2011/297153</pub-id><pub-id pub-id-type="pmid">21766041</pub-id></mixed-citation>
</ref>
<ref id="B141">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pribiag</surname><given-names>H.</given-names></name><name><surname>Stellwagen</surname><given-names>D.</given-names></name></person-group> (<year>2013</year>). <article-title>TNF-α downregulates inhibitory neurotransmission through protein phosphatase 1-dependent trafficking of GABA<sub>A</sub> receptors</article-title>. <source/>J. Neurosci.
<volume>33</volume>, <fpage>15879</fpage>–<lpage>15893</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0530-13.2013</pub-id><pub-id pub-id-type="pmid">24089494</pub-id></mixed-citation>
</ref>
<ref id="B142">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Puskarjov</surname><given-names>M.</given-names></name><name><surname>Seja</surname><given-names>P.</given-names></name><name><surname>Heron</surname><given-names>S. E.</given-names></name><name><surname>Williams</surname><given-names>T. C.</given-names></name><name><surname>Ahmad</surname><given-names>F.</given-names></name><name><surname>Iona</surname><given-names>X.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>A variant of KCC2 from patients with febrile seizures impairs neuronal Cl- extrusion and dendritic spine formation</article-title>. <source/>EMBO Rep.
<volume>15</volume>, <fpage>723</fpage>–<lpage>729</lpage>. <pub-id pub-id-type="doi">10.1002/embr.201438749</pub-id><pub-id pub-id-type="pmid">24668262</pub-id></mixed-citation>
</ref>
<ref id="B143">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramamoorthi</surname><given-names>K.</given-names></name><name><surname>Lin</surname><given-names>Y.</given-names></name></person-group> (<year>2011</year>). <article-title>The contribution of GABAergic dysfunction to neurodevelopmental disorders</article-title>. <source/>Trends Mol. Med.
<volume>17</volume>, <fpage>452</fpage>–<lpage>462</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmed.2011.03.003</pub-id><pub-id pub-id-type="pmid">21514225</pub-id></mixed-citation>
</ref>
<ref id="B144">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rathenberg</surname><given-names>J.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Palmitoylation regulates the clustering and cell surface stability of GABA<sub>A</sub> receptors</article-title>. <source/>Mol. Cell. Neurosci.
<volume>26</volume>, <fpage>251</fpage>–<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2004.01.012</pub-id><pub-id pub-id-type="pmid">15207850</pub-id></mixed-citation>
</ref>
<ref id="B145">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Regesta</surname><given-names>G.</given-names></name><name><surname>Tanganelli</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Clinical aspects and biological bases of drug-resistant epilepsies</article-title>. <source/>Epilepsy Res.
<volume>34</volume>, <fpage>109</fpage>–<lpage>122</lpage>. <pub-id pub-id-type="doi">10.1016/s0920-1211(98)00106-5</pub-id><pub-id pub-id-type="pmid">10210025</pub-id></mixed-citation>
</ref>
<ref id="B146">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Renner</surname><given-names>M.</given-names></name><name><surname>Schweizer</surname><given-names>C.</given-names></name><name><surname>Bannai</surname><given-names>H.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Levi</surname><given-names>S.</given-names></name></person-group> (<year>2012</year>). <article-title>Diffusion barriers constrain receptors at synapses</article-title>. <source/>PLoS One
<volume>7</volume>:<fpage>e43032</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0043032</pub-id><pub-id pub-id-type="pmid">22912780</pub-id></mixed-citation>
</ref>
<ref id="B147">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rivera</surname><given-names>C.</given-names></name><name><surname>Voipio</surname><given-names>J.</given-names></name><name><surname>Thomas-Crusells</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Emri</surname><given-names>Z.</given-names></name><name><surname>Sipila</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Mechanism of activity-dependent downregulation of the neuron-specific K-Cl cotransporter KCC2</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>4683</fpage>–<lpage>4691</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5265-03.2004</pub-id><pub-id pub-id-type="pmid">15140939</pub-id></mixed-citation>
</ref>
<ref id="B148">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenberg</surname><given-names>R. E.</given-names></name><name><surname>Law</surname><given-names>J. K.</given-names></name><name><surname>Yenokyan</surname><given-names>G.</given-names></name><name><surname>McGready</surname><given-names>J.</given-names></name><name><surname>Kaufmann</surname><given-names>W. E.</given-names></name><name><surname>Law</surname><given-names>P. A.</given-names></name></person-group> (<year>2009</year>). <article-title>Characteristics and concordance of autism spectrum disorders among 277 twin pairs</article-title>. <source/>Arch. Pediatr. Adolesc. Med.
<volume>163</volume>, <fpage>907</fpage>–<lpage>914</lpage>. <pub-id pub-id-type="doi">10.1001/archpediatrics.2009.98</pub-id><pub-id pub-id-type="pmid">19805709</pub-id></mixed-citation>
</ref>
<ref id="B149">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rowland</surname><given-names>A. M.</given-names></name><name><surname>Richmond</surname><given-names>J. E.</given-names></name><name><surname>Olsen</surname><given-names>J. G.</given-names></name><name><surname>Hall</surname><given-names>D. H.</given-names></name><name><surname>Bamber</surname><given-names>B. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Presynaptic terminals independently regulate synaptic clustering and autophagy of GABA<sub>A</sub> receptors in <italic>Caenorhabditis elegans</italic></article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>1711</fpage>–<lpage>1720</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.2279-05.2006</pub-id><pub-id pub-id-type="pmid">16467519</pub-id></mixed-citation>
</ref>
<ref id="B301">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>U.</given-names></name><name><surname>Knoflach</surname><given-names>F.</given-names></name></person-group> (<year>2011</year>). <article-title>Beyond classical benzodiazepines: novel therapeutic potential of GABA<sub>A</sub> receptor subtypes</article-title>. <source/>Nat. Rev. Drug. Discov.
<volume>10</volume>, <fpage>685</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1038/nrd3502</pub-id><pub-id pub-id-type="pmid">21799515</pub-id></mixed-citation>
</ref>
<ref id="B150">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rudolph</surname><given-names>U.</given-names></name><name><surname>Möhler</surname><given-names>H.</given-names></name></person-group> (<year>2004</year>). <article-title>Analysis of GABA<sub>A</sub> receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse genetics</article-title>. <source/>Annu. Rev. Pharmacol. Toxicol.
<volume>44</volume>, <fpage>475</fpage>–<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.pharmtox.44.101802.121429</pub-id><pub-id pub-id-type="pmid">14744255</pub-id></mixed-citation>
</ref>
<ref id="B151">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>J. M.</given-names></name></person-group> (<year>2000</year>). <article-title>Sodium-potassium-chloride cotransport</article-title>. <source/>Physiol. Rev.
<volume>80</volume>, <fpage>211</fpage>–<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.2000.80.1.211</pub-id><pub-id pub-id-type="pmid">10617769</pub-id></mixed-citation>
</ref>
<ref id="B152">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saliba</surname><given-names>R. S.</given-names></name><name><surname>Michels</surname><given-names>G.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Pangalos</surname><given-names>M. N.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2007</year>). <article-title>Activity-dependent ubiquitination of GABA<sub>A</sub> receptors regulates their accumulation at synaptic sites</article-title>. <source/>J. Neurosci.
<volume>27</volume>, <fpage>13341</fpage>–<lpage>13351</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.3277-07.2007</pub-id><pub-id pub-id-type="pmid">18045928</pub-id></mixed-citation>
</ref>
<ref id="B153">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saxena</surname><given-names>S.</given-names></name><name><surname>Caroni</surname><given-names>P.</given-names></name></person-group> (<year>2011</year>). <article-title>Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration</article-title>. <source/>Neuron
<volume>71</volume>, <fpage>35</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2011.06.031</pub-id><pub-id pub-id-type="pmid">21745636</pub-id></mixed-citation>
</ref>
<ref id="B154">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwarten</surname><given-names>M.</given-names></name><name><surname>Mohrluder</surname><given-names>J.</given-names></name><name><surname>Ma</surname><given-names>P.</given-names></name><name><surname>Stoldt</surname><given-names>M.</given-names></name><name><surname>Thielmann</surname><given-names>Y.</given-names></name><name><surname>Stangler</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>Nix directly binds to GABARAP: a possible crosstalk between apoptosis and autophagy</article-title>. <source/>Autophagy
<volume>5</volume>, <fpage>690</fpage>–<lpage>698</lpage>. <pub-id pub-id-type="doi">10.4161/auto.5.5.8494</pub-id><pub-id pub-id-type="pmid">19363302</pub-id></mixed-citation>
</ref>
<ref id="B302">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schwartz-Bloom</surname><given-names>R. D.</given-names></name><name><surname>Sah</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>γ-Aminobutyric acid<sub>A</sub> neurotransmission and cerebral ischemia</article-title>. <source/>J. Neurochem.
<volume>77</volume>, <fpage>353</fpage>–<lpage>371</lpage>. <pub-id pub-id-type="doi">10.1046/j.1471-4159.2001.00274.x</pub-id><pub-id pub-id-type="pmid">11299298</pub-id></mixed-citation>
</ref>
<ref id="B155">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>A. K.</given-names></name><name><surname>Reams</surname><given-names>R. Y.</given-names></name><name><surname>Jordan</surname><given-names>W. H.</given-names></name><name><surname>Miller</surname><given-names>M. A.</given-names></name><name><surname>Thacker</surname><given-names>H. L.</given-names></name><name><surname>Snyder</surname><given-names>P. W.</given-names></name></person-group> (<year>2007</year>). <article-title>Mesial temporal lobe epilepsy: pathogenesis, induced rodent models and lesions</article-title>. <source/>Toxicol. Pathol.
<volume>35</volume>, <fpage>984</fpage>–<lpage>999</lpage>. <pub-id pub-id-type="doi">10.1080/01926230701748305</pub-id><pub-id pub-id-type="pmid">18098044</pub-id></mixed-citation>
</ref>
<ref id="B156">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>A. N.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name></person-group> (<year>2011a</year>). <article-title>GABA<sub>A</sub> receptors: post-synaptic co-localization and cross-talk with other receptors</article-title>. <source/>Front. Cell. Neurosci.
<volume>5</volume>:<fpage>7</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2011.00007</pub-id><pub-id pub-id-type="pmid">21734865</pub-id></mixed-citation>
</ref>
<ref id="B157">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shrivastava</surname><given-names>A. N.</given-names></name><name><surname>Triller</surname><given-names>A.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Sarto-Jackson</surname><given-names>I.</given-names></name></person-group> (<year>2011b</year>). <article-title>Regulation of GABA<sub>A</sub> receptor dynamics by interaction with purinergic P2X<sub>2</sub> receptors</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>14455</fpage>–<lpage>14468</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M110.165282</pub-id><pub-id pub-id-type="pmid">21343285</pub-id></mixed-citation>
</ref>
<ref id="B158">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Kittler</surname><given-names>J. T.</given-names></name></person-group> (<year>2010</year>). <article-title>The cell biology of synaptic inhibition in health and disease</article-title>. <source/>Curr. Opin. Neurobiol.
<volume>20</volume>, <fpage>550</fpage>–<lpage>556</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2010.06.001</pub-id><pub-id pub-id-type="pmid">20650630</pub-id></mixed-citation>
</ref>
<ref id="B159">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>McAinsh</surname><given-names>K.</given-names></name><name><surname>Chen</surname><given-names>G.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Haucke</surname><given-names>V.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Regulation of inhibitory synaptic transmission by a conserved atypical interaction of GABA<sub>A</sub> receptor β- and γ-subunits with the clathrin AP2 adaptor</article-title>. <source/>Neuropharmacology
<volume>55</volume>, <fpage>844</fpage>–<lpage>850</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuropharm.2008.06.072</pub-id><pub-id pub-id-type="pmid">18662706</pub-id></mixed-citation>
</ref>
<ref id="B160">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Muir</surname><given-names>J.</given-names></name><name><surname>Rao</surname><given-names>Y.</given-names></name><name><surname>Browarski</surname><given-names>M.</given-names></name><name><surname>Gruenig</surname><given-names>M. C.</given-names></name><name><surname>Sheehan</surname><given-names>D. F.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Stabilization of GABA<sub>A</sub> receptors at endocytic zones is mediated by an AP2 binding motif within the GABA<sub>A</sub> receptor β3 subunit</article-title>. <source/>J. Neurosci.
<volume>32</volume>, <fpage>2485</fpage>–<lpage>2498</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.1622-11.2011</pub-id><pub-id pub-id-type="pmid">22396422</pub-id></mixed-citation>
</ref>
<ref id="B161">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>K. R.</given-names></name><name><surname>Oliver</surname><given-names>P. L.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>Revilla-Sanchez</surname><given-names>R.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Identification and characterisation of a Maf1/Macoco protein complex that interacts with GABA<sub>A</sub> receptors in neurons</article-title>. <source/>Mol. Cell. Neurosci.
<volume>44</volume>, <fpage>330</fpage>–<lpage>341</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2010.04.004</pub-id><pub-id pub-id-type="pmid">20417281</pub-id></mixed-citation>
</ref>
<ref id="B162">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staley</surname><given-names>K.</given-names></name></person-group> (<year>2015</year>). <article-title>Molecular mechanisms of epilepsy</article-title>. <source/>Nat. Neurosci.
<volume>18</volume>, <fpage>367</fpage>–<lpage>372</lpage>. <pub-id pub-id-type="doi">10.1038/nn.3947</pub-id><pub-id pub-id-type="pmid">25710839</pub-id></mixed-citation>
</ref>
<ref id="B163">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stellwagen</surname><given-names>D.</given-names></name><name><surname>Malenka</surname><given-names>R. C.</given-names></name></person-group> (<year>2006</year>). <article-title>Synaptic scaling mediated by glial TNF-α</article-title>. <source/>Nature
<volume>440</volume>, <fpage>1054</fpage>–<lpage>1059</lpage>. <pub-id pub-id-type="doi">10.1038/nature04671</pub-id><pub-id pub-id-type="pmid">16547515</pub-id></mixed-citation>
</ref>
<ref id="B164">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stelzer</surname><given-names>A.</given-names></name><name><surname>Shi</surname><given-names>H.</given-names></name></person-group> (<year>1994</year>). <article-title>Impairment of GABA<sub>A</sub> receptor function by N-methyl-D-aspartate-mediated calcium influx in isolated CA1 pyramidal cells</article-title>. <source/>Neuroscience
<volume>62</volume>, <fpage>813</fpage>–<lpage>828</lpage>. <pub-id pub-id-type="doi">10.1016/0306-4522(94)90479-0</pub-id><pub-id pub-id-type="pmid">7870309</pub-id></mixed-citation>
</ref>
<ref id="B165">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>X.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>L.</given-names></name><name><surname>Wengert</surname><given-names>E.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>KCC2 rescues functional deficits in human neurons derived from patients with Rett syndrome</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>113</volume>, <fpage>751</fpage>–<lpage>756</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1524013113</pub-id><pub-id pub-id-type="pmid">26733678</pub-id></mixed-citation>
</ref>
<ref id="B166">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Xu</surname><given-names>J.</given-names></name><name><surname>Vithlani</surname><given-names>M.</given-names></name><name><surname>Sieghart</surname><given-names>W.</given-names></name><name><surname>Kittler</surname><given-names>J.</given-names></name><name><surname>Pangalos</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Deficits in phosphorylation of GABA<sub>A</sub> receptors by intimately associated protein kinase C activity underlie compromised synaptic inhibition during status epilepticus</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>376</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.4346-07.2008</pub-id><pub-id pub-id-type="pmid">18184780</pub-id></mixed-citation>
</ref>
<ref id="B167">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thind</surname><given-names>K. K.</given-names></name><name><surname>Yamawaki</surname><given-names>R.</given-names></name><name><surname>Phanwar</surname><given-names>I.</given-names></name><name><surname>Zhang</surname><given-names>G.</given-names></name><name><surname>Wen</surname><given-names>X.</given-names></name><name><surname>Buckmaster</surname><given-names>P. S.</given-names></name></person-group> (<year>2010</year>). <article-title>Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy</article-title>. <source/>J. Comp. Neurol.
<volume>518</volume>, <fpage>647</fpage>–<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22235</pub-id><pub-id pub-id-type="pmid">20034063</pub-id></mixed-citation>
</ref>
<ref id="B168">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomas</surname><given-names>P.</given-names></name><name><surname>Mortensen</surname><given-names>M.</given-names></name><name><surname>Hosie</surname><given-names>A. M.</given-names></name><name><surname>Smart</surname><given-names>T. G.</given-names></name></person-group> (<year>2005</year>). <article-title>Dynamic mobility of functional GABA<sub>A</sub> receptors at inhibitory synapses</article-title>. <source/>Nat. Neurosci.
<volume>8</volume>, <fpage>889</fpage>–<lpage>897</lpage>. <pub-id pub-id-type="doi">10.1038/nn1483</pub-id><pub-id pub-id-type="pmid">15951809</pub-id></mixed-citation>
</ref>
<ref id="B169">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson-Vest</surname><given-names>N. M.</given-names></name><name><surname>Waldvogel</surname><given-names>H. J.</given-names></name><name><surname>Rees</surname><given-names>M. I.</given-names></name><name><surname>Faull</surname><given-names>R. L.</given-names></name></person-group> (<year>2003</year>). <article-title>GABA<sub>A</sub> receptor subunit and gephyrin protein changes differ in the globus pallidus in Huntington’s diseased brain</article-title>. <source/>Brain Res.
<volume>994</volume>, <fpage>265</fpage>–<lpage>270</lpage>. <pub-id pub-id-type="doi">10.1016/j.brainres.2003.09.051</pub-id><pub-id pub-id-type="pmid">14642653</pub-id></mixed-citation>
</ref>
<ref id="B170">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Jacob</surname><given-names>T. C.</given-names></name><name><surname>Mukherjee</surname><given-names>J.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name><name><surname>Pangalos</surname><given-names>M. N.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2008</year>). <article-title>The clustering of GABA<sub>A</sub> receptor subtypes at inhibitory synapses is facilitated via the direct binding of receptor α2 subunits to gephyrin</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>1356</fpage>–<lpage>1365</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.5050-07.2008</pub-id><pub-id pub-id-type="pmid">18256255</pub-id></mixed-citation>
</ref>
<ref id="B171">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tretter</surname><given-names>V.</given-names></name><name><surname>Kerschner</surname><given-names>B.</given-names></name><name><surname>Milenkovic</surname><given-names>I.</given-names></name><name><surname>Ramsden</surname><given-names>S. L.</given-names></name><name><surname>Ramerstorfer</surname><given-names>J.</given-names></name><name><surname>Saiepour</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Molecular basis of the γ-aminobutyric acid A receptor α3 subunit interaction with the clustering protein gephyrin</article-title>. <source/>J. Biol. Chem.
<volume>286</volume>, <fpage>37702</fpage>–<lpage>37711</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.m111.291336</pub-id><pub-id pub-id-type="pmid">21880742</pub-id></mixed-citation>
</ref>
<ref id="B172">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Twelvetrees</surname><given-names>A. E.</given-names></name><name><surname>Yuen</surname><given-names>E. Y.</given-names></name><name><surname>Arancibia-Carcamo</surname><given-names>I. L.</given-names></name><name><surname>MacAskill</surname><given-names>A. F.</given-names></name><name><surname>Rostaing</surname><given-names>P.</given-names></name><name><surname>Lumb</surname><given-names>M. J.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Delivery of GABA<sub>A</sub>Rs to synapses is mediated by HAP1-KIF5 and disrupted by mutant huntingtin</article-title>. <source/>Neuron
<volume>65</volume>, <fpage>53</fpage>–<lpage>65</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2009.12.007</pub-id><pub-id pub-id-type="pmid">20152113</pub-id></mixed-citation>
</ref>
<ref id="B173">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagarajan</surname><given-names>S. K.</given-names></name><name><surname>Fritschy</surname><given-names>J. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Gephyrin: a master regulator of neuronal function?</article-title>
<source/>Nat. Rev. Neurosci.
<volume>15</volume>, <fpage>141</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1038/nrn3670</pub-id><pub-id pub-id-type="pmid">24552784</pub-id></mixed-citation>
</ref>
<ref id="B174">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uji</surname><given-names>A.</given-names></name><name><surname>Matsuda</surname><given-names>M.</given-names></name><name><surname>Kukita</surname><given-names>T.</given-names></name><name><surname>Maeda</surname><given-names>K.</given-names></name><name><surname>Kanematsu</surname><given-names>T.</given-names></name><name><surname>Hirata</surname><given-names>M.</given-names></name></person-group> (<year>2002</year>). <article-title>Molecules interacting with PRIP-2, a novel Ins(1,4,5)P3 binding protein type 2: comparison with PRIP-1</article-title>. <source/>Life Sci.
<volume>72</volume>, <fpage>443</fpage>–<lpage>453</lpage>. <pub-id pub-id-type="doi">10.1016/s0024-3205(02)02275-0</pub-id><pub-id pub-id-type="pmid">12467885</pub-id></mixed-citation>
</ref>
<ref id="B175">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulrich</surname><given-names>D.</given-names></name></person-group> (<year>2015</year>). <article-title>Amyloid-β impairs synaptic inhibition via GABA<sub>A</sub> receptor endocytosis</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>9205</fpage>–<lpage>9210</lpage>. <pub-id pub-id-type="doi">10.1523/jneurosci.0950-15.2015</pub-id><pub-id pub-id-type="pmid">26085642</pub-id></mixed-citation>
</ref>
<ref id="B176">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>E.</given-names></name><name><surname>Juhász</surname><given-names>G.</given-names></name><name><surname>Bozsó</surname><given-names>Z.</given-names></name><name><surname>Penke</surname><given-names>B.</given-names></name><name><surname>Fülöp</surname><given-names>L.</given-names></name><name><surname>Szegedi</surname><given-names>V.</given-names></name></person-group> (<year>2014</year>). <article-title>Aβ(1–42) enhances neuronal excitability in the CA1 via NR2B subunit-containing NMDA receptors</article-title>. <source/>Neural Plast.
<volume>2014</volume>:<fpage>584314</fpage>. <pub-id pub-id-type="doi">10.1155/2014/584314</pub-id><pub-id pub-id-type="pmid">25276438</pub-id></mixed-citation>
</ref>
<ref id="B177">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vien</surname><given-names>T. N.</given-names></name><name><surname>Modgil</surname><given-names>A.</given-names></name><name><surname>Abramian</surname><given-names>A. M.</given-names></name><name><surname>Jurd</surname><given-names>R.</given-names></name><name><surname>Walker</surname><given-names>J.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Compromising the phosphodependent regulation of the GABA<sub>A</sub>R β3 subunit reproduces the core phenotypes of autism spectrum disorders</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>112</volume>, <fpage>14805</fpage>–<lpage>14810</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1514657112</pub-id><pub-id pub-id-type="pmid">26627235</pub-id></mixed-citation>
</ref>
<ref id="B178">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vignoli</surname><given-names>A.</given-names></name><name><surname>Savini</surname><given-names>M. N.</given-names></name><name><surname>Nowbut</surname><given-names>M. S.</given-names></name><name><surname>Peron</surname><given-names>A.</given-names></name><name><surname>Turner</surname><given-names>K.</given-names></name><name><surname>La Briola</surname><given-names>F.</given-names></name><etal></etal></person-group>. (<year>2017</year>). <article-title>Effectiveness and tolerability of antiepileptic drugs in 104 girls with Rett syndrome</article-title>. <source/>Epilepsy Behav.
<volume>66</volume>, <fpage>27</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.10.006</pub-id><pub-id pub-id-type="pmid">27988477</pub-id></mixed-citation>
</ref>
<ref id="B179">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vithlani</surname><given-names>M.</given-names></name><name><surname>Terunuma</surname><given-names>M.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name></person-group> (<year>2011</year>). <article-title>The dynamic modulation of GABA<sub>A</sub> receptor trafficking and its role in regulating the plasticity of inhibitory synapses</article-title>. <source/>Physiol. Rev.
<volume>91</volume>, <fpage>1009</fpage>–<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1152/physrev.00015.2010</pub-id><pub-id pub-id-type="pmid">21742794</pub-id></mixed-citation>
</ref>
<ref id="B180">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Volk</surname><given-names>L.</given-names></name><name><surname>Chiu</surname><given-names>S. L.</given-names></name><name><surname>Sharma</surname><given-names>K.</given-names></name><name><surname>Huganir</surname><given-names>R. L.</given-names></name></person-group> (<year>2015</year>). <article-title>Glutamate synapses in human cognitive disorders</article-title>. <source/>Annu. Rev. Neurosci.
<volume>38</volume>, <fpage>127</fpage>–<lpage>149</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-neuro-071714-033821</pub-id><pub-id pub-id-type="pmid">25897873</pub-id></mixed-citation>
</ref>
<ref id="B181">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>H.</given-names></name><name><surname>Bedford</surname><given-names>F. K.</given-names></name><name><surname>Brandon</surname><given-names>N. J.</given-names></name><name><surname>Moss</surname><given-names>S. J.</given-names></name><name><surname>Olsen</surname><given-names>R. W.</given-names></name></person-group> (<year>1999</year>). <article-title>GABA<sub>A</sub>-receptor-associated protein links GABA<sub>A</sub> receptors and the cytoskeleton</article-title>. <source/>Nature
<volume>397</volume>, <fpage>69</fpage>–<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1038/16264</pub-id><pub-id pub-id-type="pmid">9892355</pub-id></mixed-citation>
</ref>
<ref id="B182">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>M.</given-names></name><name><surname>Fukuda</surname><given-names>A.</given-names></name></person-group> (<year>2015</year>). <article-title>Development and regulation of chloride homeostasis in the central nervous system</article-title>. <source/>Front. Cell. Neurosci.
<volume>9</volume>:<fpage>371</fpage>. <pub-id pub-id-type="doi">10.3389/fncel.2015.00371</pub-id><pub-id pub-id-type="pmid">26441542</pub-id></mixed-citation>
</ref>
<ref id="B183">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Y. W.</given-names></name><name><surname>Sullivan</surname><given-names>J.</given-names></name><name><surname>McDaniel</surname><given-names>S. S.</given-names></name><name><surname>Meisler</surname><given-names>M. H.</given-names></name><name><surname>Walsh</surname><given-names>E. M.</given-names></name><name><surname>Li</surname><given-names>S. X.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Incidence of dravet syndrome in a US population</article-title>. <source/>Pediatrics
<volume>136</volume>, <fpage>e1310</fpage>–<lpage>e1315</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2015-1807</pub-id><pub-id pub-id-type="pmid">26438699</pub-id></mixed-citation>
</ref>
<ref id="B184">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yizhar</surname><given-names>O.</given-names></name><name><surname>Fenno</surname><given-names>L. E.</given-names></name><name><surname>Prigge</surname><given-names>M.</given-names></name><name><surname>Schneider</surname><given-names>F.</given-names></name><name><surname>Davidson</surname><given-names>T. J.</given-names></name><name><surname>O’Shea</surname><given-names>D. J.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Neocortical excitation/inhibition balance in information processing and social dysfunction</article-title>. <source/>Nature
<volume>477</volume>, <fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1038/nature10360</pub-id><pub-id pub-id-type="pmid">21796121</pub-id></mixed-citation>
</ref>
<ref id="B185">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yuen</surname><given-names>E. Y.</given-names></name><name><surname>Wei</surname><given-names>J.</given-names></name><name><surname>Zhong</surname><given-names>P.</given-names></name><name><surname>Yan</surname><given-names>Z.</given-names></name></person-group> (<year>2012</year>). <article-title>Disrupted GABA<sub>A</sub>R trafficking and synaptic inhibition in a mouse model of Huntington’s disease</article-title>. <source/>Neurobiol. Dis.
<volume>46</volume>, <fpage>497</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1016/j.nbd.2012.02.015</pub-id><pub-id pub-id-type="pmid">22402331</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>